# PeptideScanner evidence objects: Setmelanotide

Every published version of the records placed with Setmelanotide, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json. Selected public evidence only; not medical advice.

- Objects: 73
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct02896192-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT02896192

> PeptideScanner retained ClinicalTrials.gov record NCT02896192 at 2026-07-30T19:08:50.175Z. Its registry update date was 2023-09-21, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct02896192-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-09-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02896192-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct02896192-setmelanotide-v1
- Content SHA-256: `fc42aff75b923c983e7de3e3cbaab5b0e91b7f634d503e18a57cce1361cb555a`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02896192 ([`ctg-observation-nct02896192-2023-09-21-927773210842`](#source-ctg-observation-nct02896192-2023-09-21-927773210842))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02896192 at 2026-07-30T19:08:50.175Z. Its registry update date was 2023-09-21, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct02896192-2023-09-21-927773210842`](#source-ctg-observation-nct02896192-2023-09-21-927773210842))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02896192 at 2026-07-30T19:08:50.175Z. Its registry update date was 2023-09-21, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct02896192-2023-09-21-927773210842`](#source-ctg-observation-nct02896192-2023-09-21-927773210842))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02896192-2023-09-21-927773210842`](#source-ctg-observation-nct02896192-2023-09-21-927773210842))

### Sources

<a id="source-ctg-observation-nct02896192-2023-09-21-927773210842"></a>
- **ClinicalTrials.gov record NCT02896192 · retained source version 2023-09-21:927773210842649d6223a13018e39a746ee35d1d0fa87aa9583ddd8bbb7b2dd7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02896192) (`ctg-observation-nct02896192-2023-09-21-927773210842`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02896192." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct02896192-setmelanotide-v1 SHA-256: fc42aff75b923c983e7de3e3cbaab5b0e91b7f634d503e18a57cce1361cb555a.

---

<a id="clinicaltrials-gov-nct03262610-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT03262610

> PeptideScanner retained ClinicalTrials.gov record NCT03262610 at 2026-07-30T19:44:52.963Z. Its registry update date was 2022-01-04, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct03262610-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2022-01-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03262610-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct03262610-setmelanotide-v1
- Content SHA-256: `a962a34b91e2285870b3aa2c86ccc312ac58054c204c1219fbb50d751ad4cf58`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03262610 ([`ctg-observation-nct03262610-2022-01-04-8355a81fc3bb`](#source-ctg-observation-nct03262610-2022-01-04-8355a81fc3bb))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03262610 at 2026-07-30T19:44:52.963Z. Its registry update date was 2022-01-04, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03262610-2022-01-04-8355a81fc3bb`](#source-ctg-observation-nct03262610-2022-01-04-8355a81fc3bb))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03262610 at 2026-07-30T19:44:52.963Z. Its registry update date was 2022-01-04, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03262610-2022-01-04-8355a81fc3bb`](#source-ctg-observation-nct03262610-2022-01-04-8355a81fc3bb))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03262610-2022-01-04-8355a81fc3bb`](#source-ctg-observation-nct03262610-2022-01-04-8355a81fc3bb))

### Sources

<a id="source-ctg-observation-nct03262610-2022-01-04-8355a81fc3bb"></a>
- **ClinicalTrials.gov record NCT03262610 · retained source version 2022-01-04:8355a81fc3bb91e526577eaf3eefd7fb29b3a1946f58d33f6df2b8af6d4b0d57** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03262610) (`ctg-observation-nct03262610-2022-01-04-8355a81fc3bb`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03262610." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct03262610-setmelanotide-v1 SHA-256: a962a34b91e2285870b3aa2c86ccc312ac58054c204c1219fbb50d751ad4cf58.

---

<a id="clinicaltrials-gov-nct03287960-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT03287960

> PeptideScanner retained ClinicalTrials.gov record NCT03287960 at 2026-07-30T19:13:03.752Z. Its registry update date was 2023-05-23, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct03287960-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-05-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03287960-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct03287960-setmelanotide-v1
- Content SHA-256: `06272fbe514ae3beb7bee4c10847265570e051c5fbf753967df552890a92fc55`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03287960 ([`ctg-observation-nct03287960-2023-05-23-71c87a33ef5d`](#source-ctg-observation-nct03287960-2023-05-23-71c87a33ef5d))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03287960 at 2026-07-30T19:13:03.752Z. Its registry update date was 2023-05-23, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03287960-2023-05-23-71c87a33ef5d`](#source-ctg-observation-nct03287960-2023-05-23-71c87a33ef5d))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03287960 at 2026-07-30T19:13:03.752Z. Its registry update date was 2023-05-23, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03287960-2023-05-23-71c87a33ef5d`](#source-ctg-observation-nct03287960-2023-05-23-71c87a33ef5d))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03287960-2023-05-23-71c87a33ef5d`](#source-ctg-observation-nct03287960-2023-05-23-71c87a33ef5d))

### Sources

<a id="source-ctg-observation-nct03287960-2023-05-23-71c87a33ef5d"></a>
- **ClinicalTrials.gov record NCT03287960 · retained source version 2023-05-23:71c87a33ef5d995b7ce04b8fa78c4cecf7abec3b24ba5551d2bee29fd50c9fd4** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03287960) (`ctg-observation-nct03287960-2023-05-23-71c87a33ef5d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03287960." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct03287960-setmelanotide-v1 SHA-256: 06272fbe514ae3beb7bee4c10847265570e051c5fbf753967df552890a92fc55.

---

<a id="clinicaltrials-gov-nct03651765-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT03651765

> PeptideScanner retained ClinicalTrials.gov record NCT03651765 at 2026-07-30T18:27:14.161Z. Its registry update date was 2025-05-31, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct03651765-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-05-31
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03651765-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct03651765-setmelanotide-v1
- Content SHA-256: `82882399dbc2e324f226e304a8b00df2f5c255b75be1ced28855c5866cdf2a4a`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03651765 ([`ctg-observation-nct03651765-2025-05-31-de63add01879`](#source-ctg-observation-nct03651765-2025-05-31-de63add01879))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03651765 at 2026-07-30T18:27:14.161Z. Its registry update date was 2025-05-31, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03651765-2025-05-31-de63add01879`](#source-ctg-observation-nct03651765-2025-05-31-de63add01879))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03651765 at 2026-07-30T18:27:14.161Z. Its registry update date was 2025-05-31, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct03651765-2025-05-31-de63add01879`](#source-ctg-observation-nct03651765-2025-05-31-de63add01879))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03651765-2025-05-31-de63add01879`](#source-ctg-observation-nct03651765-2025-05-31-de63add01879))

### Sources

<a id="source-ctg-observation-nct03651765-2025-05-31-de63add01879"></a>
- **ClinicalTrials.gov record NCT03651765 · retained source version 2025-05-31:de63add01879f55e83df498a9cc110668a1655ca46e495ff9b59ba2721836ecc** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03651765) (`ctg-observation-nct03651765-2025-05-31-de63add01879`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03651765." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct03651765-setmelanotide-v1 SHA-256: 82882399dbc2e324f226e304a8b00df2f5c255b75be1ced28855c5866cdf2a4a.

---

<a id="clinicaltrials-gov-nct04725240-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT04725240

> PeptideScanner retained ClinicalTrials.gov record NCT04725240 at 2026-07-30T18:31:14.558Z. Its registry update date was 2025-02-07, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct04725240-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-02-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04725240-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct04725240-setmelanotide-v1
- Content SHA-256: `06ab41824fae810ffa8b98e266a6dec7178b3871af4868f02cdff7698b2423ef`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT04725240 ([`ctg-observation-nct04725240-2025-02-07-a4aac0175c62`](#source-ctg-observation-nct04725240-2025-02-07-a4aac0175c62))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04725240 at 2026-07-30T18:31:14.558Z. Its registry update date was 2025-02-07, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct04725240-2025-02-07-a4aac0175c62`](#source-ctg-observation-nct04725240-2025-02-07-a4aac0175c62))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04725240 at 2026-07-30T18:31:14.558Z. Its registry update date was 2025-02-07, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct04725240-2025-02-07-a4aac0175c62`](#source-ctg-observation-nct04725240-2025-02-07-a4aac0175c62))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04725240-2025-02-07-a4aac0175c62`](#source-ctg-observation-nct04725240-2025-02-07-a4aac0175c62))

### Sources

<a id="source-ctg-observation-nct04725240-2025-02-07-a4aac0175c62"></a>
- **ClinicalTrials.gov record NCT04725240 · retained source version 2025-02-07:a4aac0175c624c8c03461fac57683dec725fd4748bdae4cd1696bbd8aee0fdd3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04725240) (`ctg-observation-nct04725240-2025-02-07-a4aac0175c62`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04725240." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct04725240-setmelanotide-v1 SHA-256: 06ab41824fae810ffa8b98e266a6dec7178b3871af4868f02cdff7698b2423ef.

---

<a id="clinicaltrials-gov-nct04966741-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT04966741

> PeptideScanner retained ClinicalTrials.gov record NCT04966741 at 2026-07-30T18:38:25.516Z. Its registry update date was 2024-11-27, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct04966741-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-11-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04966741-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct04966741-setmelanotide-v1
- Content SHA-256: `2d0c016284ee1e00fc038d4f9350823bf2a25ba876059bd627add25c05da66df`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT04966741 ([`ctg-observation-nct04966741-2024-11-27-5fdd20edcc60`](#source-ctg-observation-nct04966741-2024-11-27-5fdd20edcc60))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04966741 at 2026-07-30T18:38:25.516Z. Its registry update date was 2024-11-27, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct04966741-2024-11-27-5fdd20edcc60`](#source-ctg-observation-nct04966741-2024-11-27-5fdd20edcc60))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04966741 at 2026-07-30T18:38:25.516Z. Its registry update date was 2024-11-27, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct04966741-2024-11-27-5fdd20edcc60`](#source-ctg-observation-nct04966741-2024-11-27-5fdd20edcc60))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04966741-2024-11-27-5fdd20edcc60`](#source-ctg-observation-nct04966741-2024-11-27-5fdd20edcc60))

### Sources

<a id="source-ctg-observation-nct04966741-2024-11-27-5fdd20edcc60"></a>
- **ClinicalTrials.gov record NCT04966741 · retained source version 2024-11-27:5fdd20edcc60cd26c03d02de26baef3d106496449e683e66fe1716de5121bf66** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04966741) (`ctg-observation-nct04966741-2024-11-27-5fdd20edcc60`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04966741." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct04966741-setmelanotide-v1 SHA-256: 2d0c016284ee1e00fc038d4f9350823bf2a25ba876059bd627add25c05da66df.

---

<a id="clinicaltrials-gov-nct05046132-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT05046132

> PeptideScanner retained ClinicalTrials.gov record NCT05046132 at 2026-07-30T18:45:10.886Z. Its registry update date was 2024-05-03, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct05046132-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-05-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05046132-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct05046132-setmelanotide-v1
- Content SHA-256: `09eadc95cc3100ef1b04f8791d98442bfb9f6b3b7c3f1501bca58a37845e02e9`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05046132 ([`ctg-observation-nct05046132-2024-05-03-a9c26eae2c8f`](#source-ctg-observation-nct05046132-2024-05-03-a9c26eae2c8f))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05046132 at 2026-07-30T18:45:10.886Z. Its registry update date was 2024-05-03, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct05046132-2024-05-03-a9c26eae2c8f`](#source-ctg-observation-nct05046132-2024-05-03-a9c26eae2c8f))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05046132 at 2026-07-30T18:45:10.886Z. Its registry update date was 2024-05-03, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct05046132-2024-05-03-a9c26eae2c8f`](#source-ctg-observation-nct05046132-2024-05-03-a9c26eae2c8f))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05046132-2024-05-03-a9c26eae2c8f`](#source-ctg-observation-nct05046132-2024-05-03-a9c26eae2c8f))

### Sources

<a id="source-ctg-observation-nct05046132-2024-05-03-a9c26eae2c8f"></a>
- **ClinicalTrials.gov record NCT05046132 · retained source version 2024-05-03:a9c26eae2c8f6c5e7e8ef78e68ad6eeae7eb9f52444a89dc8437ffd74d170c8c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05046132) (`ctg-observation-nct05046132-2024-05-03-a9c26eae2c8f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05046132." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct05046132-setmelanotide-v1 SHA-256: 09eadc95cc3100ef1b04f8791d98442bfb9f6b3b7c3f1501bca58a37845e02e9.

---

<a id="clinicaltrials-gov-nct05093634-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT05093634

> PeptideScanner retained ClinicalTrials.gov record NCT05093634 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct05093634-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-06
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05093634-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct05093634-setmelanotide-v1
- Content SHA-256: `8289ae6fa8d031395c73472af2414543be2a162e457ed1808e60f3d8b41324bc`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05093634 ([`ctg-observation-nct05093634-2026-08-06-24ea1a709c92`](#source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05093634 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct05093634-2026-08-06-24ea1a709c92`](#source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05093634 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct05093634-2026-08-06-24ea1a709c92`](#source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05093634-2026-08-06-24ea1a709c92`](#source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92))

### Sources

<a id="source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92"></a>
- **ClinicalTrials.gov record NCT05093634 · retained source version 2026-08-06:24ea1a709c92d6093cba430d429e812dc7c56a2c2a6545b6528653665c4929e6** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05093634) (`ctg-observation-nct05093634-2026-08-06-24ea1a709c92`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05093634." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct05093634-setmelanotide-v1 SHA-256: 8289ae6fa8d031395c73472af2414543be2a162e457ed1808e60f3d8b41324bc.

---

<a id="clinicaltrials-gov-nct05093634-setmelanotide-v2"></a>

## ClinicalTrials.gov record NCT05093634

> PeptideScanner retained ClinicalTrials.gov record NCT05093634 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct05093634-setmelanotide:v2`
- Evidence domain: Clinical trials
- Date in source: 2026-11-12
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05093634-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct05093634-setmelanotide-v2
- Content SHA-256: `fb8aa3bbccd5f65f969c06b96df6ee6f54a57e6a827719c78c3b0c073d242610`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05093634 ([`ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2`](#source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05093634 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2`](#source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05093634 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2`](#source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2`](#source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2))

### Sources

<a id="source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2"></a>
- **ClinicalTrials.gov record NCT05093634 · retained source version 2026-11-12:4cfc921cdd73a4b408e9c9fb1bf840413272b2e95a275ebeaebded8bd5758d1f** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05093634) (`ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2`)

### Correction lineage

updated on 2026-11-15: ClinicalTrials.gov posted a newer version of NCT05093634, with a registry update date of 2026-11-12. This version reports that observation; the earlier retained observation remains available as version 1.
- Supersedes version: 1
- Correction sources: [`ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2`](#source-ctg-observation-nct05093634-2026-08-06-24ea1a709c92-r2)

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05093634." Version 2, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct05093634-setmelanotide-v2 SHA-256: fb8aa3bbccd5f65f969c06b96df6ee6f54a57e6a827719c78c3b0c073d242610.

---

<a id="clinicaltrials-gov-nct05774756-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT05774756

> PeptideScanner retained ClinicalTrials.gov record NCT05774756 at 2026-07-30T16:19:36.905Z. Its registry update date was 2026-05-29, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct05774756-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-05-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05774756-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct05774756-setmelanotide-v1
- Content SHA-256: `7e34f7f0bb91a0bcf6ca708817a1cd881366cf4f5635e9b3f1710ab00fa5e2b1`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05774756 ([`ctg-observation-nct05774756-2026-05-29-9dd2212b9880`](#source-ctg-observation-nct05774756-2026-05-29-9dd2212b9880))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05774756 at 2026-07-30T16:19:36.905Z. Its registry update date was 2026-05-29, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct05774756-2026-05-29-9dd2212b9880`](#source-ctg-observation-nct05774756-2026-05-29-9dd2212b9880))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05774756 at 2026-07-30T16:19:36.905Z. Its registry update date was 2026-05-29, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct05774756-2026-05-29-9dd2212b9880`](#source-ctg-observation-nct05774756-2026-05-29-9dd2212b9880))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05774756-2026-05-29-9dd2212b9880`](#source-ctg-observation-nct05774756-2026-05-29-9dd2212b9880))

### Sources

<a id="source-ctg-observation-nct05774756-2026-05-29-9dd2212b9880"></a>
- **ClinicalTrials.gov record NCT05774756 · retained source version 2026-05-29:9dd2212b988011ec2d6f8b82780c7e53d133c48228f51a40dcdb9ddcaa8d53a5** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05774756) (`ctg-observation-nct05774756-2026-05-29-9dd2212b9880`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05774756." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct05774756-setmelanotide-v1 SHA-256: 7e34f7f0bb91a0bcf6ca708817a1cd881366cf4f5635e9b3f1710ab00fa5e2b1.

---

<a id="clinicaltrials-gov-nct06596135-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT06596135

> PeptideScanner retained ClinicalTrials.gov record NCT06596135 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct06596135-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-15
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06596135-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct06596135-setmelanotide-v1
- Content SHA-256: `5fb3d8893034c8341ebbed2390d05fb6233d691ce981e36998af86c514c12ca2`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06596135 ([`ctg-observation-nct06596135-2026-07-15-5d8bb721e5ef`](#source-ctg-observation-nct06596135-2026-07-15-5d8bb721e5ef))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06596135 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct06596135-2026-07-15-5d8bb721e5ef`](#source-ctg-observation-nct06596135-2026-07-15-5d8bb721e5ef))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06596135 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct06596135-2026-07-15-5d8bb721e5ef`](#source-ctg-observation-nct06596135-2026-07-15-5d8bb721e5ef))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06596135-2026-07-15-5d8bb721e5ef`](#source-ctg-observation-nct06596135-2026-07-15-5d8bb721e5ef))

### Sources

<a id="source-ctg-observation-nct06596135-2026-07-15-5d8bb721e5ef"></a>
- **ClinicalTrials.gov record NCT06596135 · retained source version 2026-07-15:5d8bb721e5ef42636886ed5d9ca04ee4c9f301875efacb6927e6ec2e3cc5659e** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06596135) (`ctg-observation-nct06596135-2026-07-15-5d8bb721e5ef`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06596135." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct06596135-setmelanotide-v1 SHA-256: 5fb3d8893034c8341ebbed2390d05fb6233d691ce981e36998af86c514c12ca2.

---

<a id="clinicaltrials-gov-nct06760546-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT06760546

> PeptideScanner retained ClinicalTrials.gov record NCT06760546 at 2026-07-30T16:23:45.658Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct06760546-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-02-12
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06760546-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct06760546-setmelanotide-v1
- Content SHA-256: `958c9844b552bf7465071f5e771862cbdeeeb496c8f33e6420934c625ebba840`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06760546 ([`ctg-observation-nct06760546-2026-02-12-2b335c197730`](#source-ctg-observation-nct06760546-2026-02-12-2b335c197730))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06760546 at 2026-07-30T16:23:45.658Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct06760546-2026-02-12-2b335c197730`](#source-ctg-observation-nct06760546-2026-02-12-2b335c197730))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06760546 at 2026-07-30T16:23:45.658Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct06760546-2026-02-12-2b335c197730`](#source-ctg-observation-nct06760546-2026-02-12-2b335c197730))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06760546-2026-02-12-2b335c197730`](#source-ctg-observation-nct06760546-2026-02-12-2b335c197730))

### Sources

<a id="source-ctg-observation-nct06760546-2026-02-12-2b335c197730"></a>
- **ClinicalTrials.gov record NCT06760546 · retained source version 2026-02-12:2b335c197730e4c4710a8f3dd2f266b85507c83ce9af21c0b0c5f93593d31319** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06760546) (`ctg-observation-nct06760546-2026-02-12-2b335c197730`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06760546." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct06760546-setmelanotide-v1 SHA-256: 958c9844b552bf7465071f5e771862cbdeeeb496c8f33e6420934c625ebba840.

---

<a id="clinicaltrials-gov-nct06772597-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT06772597

> PeptideScanner retained ClinicalTrials.gov record NCT06772597 at 2026-07-30T16:23:45.672Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct06772597-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-02-12
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06772597-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct06772597-setmelanotide-v1
- Content SHA-256: `1ed719e947e5393ca5d9f3a56033856b174a68284d13ea99f3eede8aed6bfac6`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06772597 ([`ctg-observation-nct06772597-2026-02-12-ba49a51071c7`](#source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06772597 at 2026-07-30T16:23:45.672Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct06772597-2026-02-12-ba49a51071c7`](#source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06772597 at 2026-07-30T16:23:45.672Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct06772597-2026-02-12-ba49a51071c7`](#source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06772597-2026-02-12-ba49a51071c7`](#source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7))

### Sources

<a id="source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7"></a>
- **ClinicalTrials.gov record NCT06772597 · retained source version 2026-02-12:ba49a51071c731f07dfb804035bc18108d093a2b5a5c1e95a3ed0ebb70eef657** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06772597) (`ctg-observation-nct06772597-2026-02-12-ba49a51071c7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06772597." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct06772597-setmelanotide-v1 SHA-256: 1ed719e947e5393ca5d9f3a56033856b174a68284d13ea99f3eede8aed6bfac6.

---

<a id="clinicaltrials-gov-nct06772597-setmelanotide-v2"></a>

## ClinicalTrials.gov record NCT06772597

> PeptideScanner retained ClinicalTrials.gov record NCT06772597 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct06772597-setmelanotide:v2`
- Evidence domain: Clinical trials
- Date in source: 2026-11-13
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06772597-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct06772597-setmelanotide-v2
- Content SHA-256: `11557873e857612a8f5fd38a4cc667a7815f76020542e8d0e4f5189177f88afa`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06772597 ([`ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2`](#source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06772597 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2`](#source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06772597 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2`](#source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2`](#source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2))

### Sources

<a id="source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2"></a>
- **ClinicalTrials.gov record NCT06772597 · retained source version 2026-11-13:f413116e97e48182082a683981946cb5b2332362aed671300f7d2f0f9d0d867d** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06772597) (`ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2`)

### Correction lineage

updated on 2026-11-15: ClinicalTrials.gov posted a newer version of NCT06772597, with a registry update date of 2026-11-13. This version reports that observation; the earlier retained observation remains available as version 1.
- Supersedes version: 1
- Correction sources: [`ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2`](#source-ctg-observation-nct06772597-2026-02-12-ba49a51071c7-r2)

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06772597." Version 2, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct06772597-setmelanotide-v2 SHA-256: 11557873e857612a8f5fd38a4cc667a7815f76020542e8d0e4f5189177f88afa.

---

<a id="clinicaltrials-gov-nct07496463-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT07496463

> PeptideScanner retained ClinicalTrials.gov record NCT07496463 at 2026-08-10T18:10:04.219Z. Its registry update date was 2026-07-23, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct07496463-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-23
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07496463-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct07496463-setmelanotide-v1
- Content SHA-256: `7316d7c89e9363d4f9a5918479fa9275c58987baca6a20305c17d128c55904a0`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07496463 ([`ctg-observation-nct07496463-2026-07-23-2aace389c2c9`](#source-ctg-observation-nct07496463-2026-07-23-2aace389c2c9))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07496463 at 2026-08-10T18:10:04.219Z. Its registry update date was 2026-07-23, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct07496463-2026-07-23-2aace389c2c9`](#source-ctg-observation-nct07496463-2026-07-23-2aace389c2c9))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07496463 at 2026-08-10T18:10:04.219Z. Its registry update date was 2026-07-23, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct07496463-2026-07-23-2aace389c2c9`](#source-ctg-observation-nct07496463-2026-07-23-2aace389c2c9))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07496463-2026-07-23-2aace389c2c9`](#source-ctg-observation-nct07496463-2026-07-23-2aace389c2c9))

### Sources

<a id="source-ctg-observation-nct07496463-2026-07-23-2aace389c2c9"></a>
- **ClinicalTrials.gov record NCT07496463 · retained source version 2026-07-23:2aace389c2c9cc25663507e7e5e0b7dc7222607530fcbe9b249e29e4dc6a279c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07496463) (`ctg-observation-nct07496463-2026-07-23-2aace389c2c9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07496463." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct07496463-setmelanotide-v1 SHA-256: 7316d7c89e9363d4f9a5918479fa9275c58987baca6a20305c17d128c55904a0.

---

<a id="clinicaltrials-gov-nct07674290-setmelanotide-v1"></a>

## ClinicalTrials.gov record NCT07674290

> PeptideScanner retained ClinicalTrials.gov record NCT07674290 at 2026-07-30T16:19:03.062Z. Its registry update date was 2026-06-29, and PeptideScanner's reviewed identity mapping was setmelanotide.

- Evidence object: `story:clinicaltrials-gov-nct07674290-setmelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-06-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07674290-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct07674290-setmelanotide-v1
- Content SHA-256: `1bbd93a1a1c76502597647e7b88ffca39dee9c464ec0488b33a996aa91ead14f`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07674290 ([`ctg-observation-nct07674290-2026-06-29-f3ccc43f4657`](#source-ctg-observation-nct07674290-2026-06-29-f3ccc43f4657))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07674290 at 2026-07-30T16:19:03.062Z. Its registry update date was 2026-06-29, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct07674290-2026-06-29-f3ccc43f4657`](#source-ctg-observation-nct07674290-2026-06-29-f3ccc43f4657))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07674290 at 2026-07-30T16:19:03.062Z. Its registry update date was 2026-06-29, and PeptideScanner's reviewed identity mapping was setmelanotide. ([`ctg-observation-nct07674290-2026-06-29-f3ccc43f4657`](#source-ctg-observation-nct07674290-2026-06-29-f3ccc43f4657))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07674290-2026-06-29-f3ccc43f4657`](#source-ctg-observation-nct07674290-2026-06-29-f3ccc43f4657))

### Sources

<a id="source-ctg-observation-nct07674290-2026-06-29-f3ccc43f4657"></a>
- **ClinicalTrials.gov record NCT07674290 · retained source version 2026-06-29:f3ccc43f465728b8e959625065171a3bc241a9fc459f0286552de0f66f4b7943** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07674290) (`ctg-observation-nct07674290-2026-06-29-f3ccc43f4657`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07674290." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#clinicaltrials-gov-nct07674290-setmelanotide-v1 SHA-256: 1bbd93a1a1c76502597647e7b88ffca39dee9c464ec0488b33a996aa91ead14f.

---

<a id="dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-v1"></a>

## Setmelanotide DailyMed SPL version 12

> DailyMed lists Structured Product Labeling version 12 for the reviewed Setmelanotide label family with a published date of 2025-09-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12:v1`
- Evidence domain: Regulatory
- Date in source: 2025-09-05
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-v1
- Content SHA-256: `b06ce4c36d284fd37f8f4d819b7114a08fa4619eef3d2a952b0138e3a995915e`

### Claims and source pins

#### Headline

Setmelanotide DailyMed SPL version 12 ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-history))

#### Summary

DailyMed lists Structured Product Labeling version 12 for the reviewed Setmelanotide label family with a published date of 2025-09-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 12 for the reviewed Setmelanotide label family with a published date of 2025-09-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-history))

### Sources

<a id="source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-history"></a>
- **DailyMed SPL SET ID 70c3ccf7-4df0-4c75-ba07-fede9970c8d9 · SPL version 12 · published 2025-09-05 · retained ZIP SHA-256 1b6551ccd1b923a4c98e2d7ba097040f596aa064484550fcd7e3e62bc5d144dd** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=12) (`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide DailyMed SPL version 12." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v12-v1 SHA-256: b06ce4c36d284fd37f8f4d819b7114a08fa4619eef3d2a952b0138e3a995915e.

---

<a id="dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-v1"></a>

## Setmelanotide DailyMed SPL version 13

> DailyMed lists Structured Product Labeling version 13 for the reviewed Setmelanotide label family with a published date of 2025-12-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13:v1`
- Evidence domain: Regulatory
- Date in source: 2025-12-22
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-v1
- Content SHA-256: `26c85453df40a4075758f1f0e504aea0e9b542e64ac5b1ea98470afdca5f924c`

### Claims and source pins

#### Headline

Setmelanotide DailyMed SPL version 13 ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-history))

#### Summary

DailyMed lists Structured Product Labeling version 13 for the reviewed Setmelanotide label family with a published date of 2025-12-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 13 for the reviewed Setmelanotide label family with a published date of 2025-12-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-history))

### Sources

<a id="source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-history"></a>
- **DailyMed SPL SET ID 70c3ccf7-4df0-4c75-ba07-fede9970c8d9 · SPL version 13 · published 2025-12-22 · retained ZIP SHA-256 bd3173681d44e195d3c1d98ad8c8a1dd13006960c616072827afbb7962d4512b** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=13) (`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide DailyMed SPL version 13." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v13-v1 SHA-256: 26c85453df40a4075758f1f0e504aea0e9b542e64ac5b1ea98470afdca5f924c.

---

<a id="dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-v1"></a>

## Setmelanotide DailyMed SPL version 14

> DailyMed lists Structured Product Labeling version 14 for the reviewed Setmelanotide label family with a published date of 2026-04-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14:v1`
- Evidence domain: Regulatory
- Date in source: 2026-04-02
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-v1
- Content SHA-256: `609a1ded6a39869ba20368c39567616a4a44e5bbfc2cd32afc750980b40d37aa`

### Claims and source pins

#### Headline

Setmelanotide DailyMed SPL version 14 ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-history))

#### Summary

DailyMed lists Structured Product Labeling version 14 for the reviewed Setmelanotide label family with a published date of 2026-04-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 14 for the reviewed Setmelanotide label family with a published date of 2026-04-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-history))

### Sources

<a id="source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-history"></a>
- **DailyMed SPL SET ID 70c3ccf7-4df0-4c75-ba07-fede9970c8d9 · SPL version 14 · published 2026-04-02 · retained ZIP SHA-256 3a9024abc434e828923d30e4f860e834f3887ceece2a7a47cdc1c8828105e6f1** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=14) (`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide DailyMed SPL version 14." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v14-v1 SHA-256: 609a1ded6a39869ba20368c39567616a4a44e5bbfc2cd32afc750980b40d37aa.

---

<a id="dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-v1"></a>

## Setmelanotide DailyMed SPL version 1

> DailyMed lists Structured Product Labeling version 1 for the reviewed Setmelanotide label family with a published date of 2020-12-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1:v1`
- Evidence domain: Regulatory
- Date in source: 2020-12-16
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-v1
- Content SHA-256: `17fff1fa50e31618ddf5b0557cb86411060145e352774bc83930e34705caa68c`

### Claims and source pins

#### Headline

Setmelanotide DailyMed SPL version 1 ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-history))

#### Summary

DailyMed lists Structured Product Labeling version 1 for the reviewed Setmelanotide label family with a published date of 2020-12-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 1 for the reviewed Setmelanotide label family with a published date of 2020-12-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-history))

### Sources

<a id="source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-history"></a>
- **DailyMed SPL SET ID 70c3ccf7-4df0-4c75-ba07-fede9970c8d9 · SPL version 1 · published 2020-12-16 · retained ZIP SHA-256 b84c8f9db67a454b2dadf55f4cfac8d72c052753b0bb05ddb25d896622df5fc8** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=1) (`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide DailyMed SPL version 1." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v1-v1 SHA-256: 17fff1fa50e31618ddf5b0557cb86411060145e352774bc83930e34705caa68c.

---

<a id="dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-v1"></a>

## Setmelanotide DailyMed SPL version 3

> DailyMed lists Structured Product Labeling version 3 for the reviewed Setmelanotide label family with a published date of 2022-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3:v1`
- Evidence domain: Regulatory
- Date in source: 2022-04-12
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-v1
- Content SHA-256: `00b86e999f3473c0070ab9f7fe6588f12b8415d9510621fb39b6aec1b8fdcf1e`

### Claims and source pins

#### Headline

Setmelanotide DailyMed SPL version 3 ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-history))

#### Summary

DailyMed lists Structured Product Labeling version 3 for the reviewed Setmelanotide label family with a published date of 2022-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 3 for the reviewed Setmelanotide label family with a published date of 2022-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-history))

### Sources

<a id="source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-history"></a>
- **DailyMed SPL SET ID 70c3ccf7-4df0-4c75-ba07-fede9970c8d9 · SPL version 3 · published 2022-04-12 · retained ZIP SHA-256 289e7ee0e8716613767b9e8681023af9c11e1d8b07be4748f2b84e7c8cb78eeb** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=3) (`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide DailyMed SPL version 3." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v3-v1 SHA-256: 00b86e999f3473c0070ab9f7fe6588f12b8415d9510621fb39b6aec1b8fdcf1e.

---

<a id="dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-v1"></a>

## Setmelanotide DailyMed SPL version 4

> DailyMed lists Structured Product Labeling version 4 for the reviewed Setmelanotide label family with a published date of 2022-04-27. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4:v1`
- Evidence domain: Regulatory
- Date in source: 2022-04-27
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-v1
- Content SHA-256: `c3e45ea2b17918792f49ac04bcfd842ef70a9322390655ec460f581121c45c4c`

### Claims and source pins

#### Headline

Setmelanotide DailyMed SPL version 4 ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-history))

#### Summary

DailyMed lists Structured Product Labeling version 4 for the reviewed Setmelanotide label family with a published date of 2022-04-27. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 4 for the reviewed Setmelanotide label family with a published date of 2022-04-27. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-history))

### Sources

<a id="source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-history"></a>
- **DailyMed SPL SET ID 70c3ccf7-4df0-4c75-ba07-fede9970c8d9 · SPL version 4 · published 2022-04-27 · retained ZIP SHA-256 0f4d0dadba00dbf622d7261307d32464b0f998c0088392f3545ba88b0441c9f3** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=4) (`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide DailyMed SPL version 4." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v4-v1 SHA-256: c3e45ea2b17918792f49ac04bcfd842ef70a9322390655ec460f581121c45c4c.

---

<a id="dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-v1"></a>

## Setmelanotide DailyMed SPL version 5

> DailyMed lists Structured Product Labeling version 5 for the reviewed Setmelanotide label family with a published date of 2022-07-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5:v1`
- Evidence domain: Regulatory
- Date in source: 2022-07-04
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-v1
- Content SHA-256: `9a2cdb92f76e5486f510f849f2b876a9ade9dbb5b1cafdde313ff47b2a04a868`

### Claims and source pins

#### Headline

Setmelanotide DailyMed SPL version 5 ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-history))

#### Summary

DailyMed lists Structured Product Labeling version 5 for the reviewed Setmelanotide label family with a published date of 2022-07-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 5 for the reviewed Setmelanotide label family with a published date of 2022-07-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-history))

### Sources

<a id="source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-history"></a>
- **DailyMed SPL SET ID 70c3ccf7-4df0-4c75-ba07-fede9970c8d9 · SPL version 5 · published 2022-07-04 · retained ZIP SHA-256 368be505eccbb11f3f17236605447b3ec508a6168caac1581412f6a475ccb4cd** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=5) (`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide DailyMed SPL version 5." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v5-v1 SHA-256: 9a2cdb92f76e5486f510f849f2b876a9ade9dbb5b1cafdde313ff47b2a04a868.

---

<a id="dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-v1"></a>

## Setmelanotide DailyMed SPL version 6

> DailyMed lists Structured Product Labeling version 6 for the reviewed Setmelanotide label family with a published date of 2023-11-29. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6:v1`
- Evidence domain: Regulatory
- Date in source: 2023-11-29
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-v1
- Content SHA-256: `be719eba4839b222cc5694e69cb0fe6556ca2b8b6e4f7a4f87f7654ad25efe12`

### Claims and source pins

#### Headline

Setmelanotide DailyMed SPL version 6 ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-history))

#### Summary

DailyMed lists Structured Product Labeling version 6 for the reviewed Setmelanotide label family with a published date of 2023-11-29. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 6 for the reviewed Setmelanotide label family with a published date of 2023-11-29. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-history))

### Sources

<a id="source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-history"></a>
- **DailyMed SPL SET ID 70c3ccf7-4df0-4c75-ba07-fede9970c8d9 · SPL version 6 · published 2023-11-29 · retained ZIP SHA-256 ae324924b5d44bbe5e1220c1134564fc4ab44b45f9e436ff1fce7e2ed948c85a** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=6) (`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide DailyMed SPL version 6." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v6-v1 SHA-256: be719eba4839b222cc5694e69cb0fe6556ca2b8b6e4f7a4f87f7654ad25efe12.

---

<a id="dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-v1"></a>

## Setmelanotide DailyMed SPL version 8

> DailyMed lists Structured Product Labeling version 8 for the reviewed Setmelanotide label family with a published date of 2025-05-19. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8:v1`
- Evidence domain: Regulatory
- Date in source: 2025-05-19
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-v1
- Content SHA-256: `ade90e40bb33dfc1f1a0955567cec336c904c90e772e3561592c83aed3e45170`

### Claims and source pins

#### Headline

Setmelanotide DailyMed SPL version 8 ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-history))

#### Summary

DailyMed lists Structured Product Labeling version 8 for the reviewed Setmelanotide label family with a published date of 2025-05-19. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 8 for the reviewed Setmelanotide label family with a published date of 2025-05-19. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-history))

### Sources

<a id="source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-history"></a>
- **DailyMed SPL SET ID 70c3ccf7-4df0-4c75-ba07-fede9970c8d9 · SPL version 8 · published 2025-05-19 · retained ZIP SHA-256 0c923dbdc6d21e76c0b0a37df9698c0795ceb2fd59cf0d41dea9abba0ff2515d** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=8) (`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide DailyMed SPL version 8." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v8-v1 SHA-256: ade90e40bb33dfc1f1a0955567cec336c904c90e772e3561592c83aed3e45170.

---

<a id="dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-v1"></a>

## Setmelanotide DailyMed SPL version 9

> DailyMed lists Structured Product Labeling version 9 for the reviewed Setmelanotide label family with a published date of 2025-05-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9:v1`
- Evidence domain: Regulatory
- Date in source: 2025-05-23
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-v1
- Content SHA-256: `3375ec62598fed729a98734dd642c763ceb5c6301d3cc3c5d18897f8c2c362f6`

### Claims and source pins

#### Headline

Setmelanotide DailyMed SPL version 9 ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-history))

#### Summary

DailyMed lists Structured Product Labeling version 9 for the reviewed Setmelanotide label family with a published date of 2025-05-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 9 for the reviewed Setmelanotide label family with a published date of 2025-05-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-history`](#source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-history))

### Sources

<a id="source-dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-history"></a>
- **DailyMed SPL SET ID 70c3ccf7-4df0-4c75-ba07-fede9970c8d9 · SPL version 9 · published 2025-05-23 · retained ZIP SHA-256 820af867ea8d47e423f3292114cebce0b7a22ab6c241183156ed4658bba11960** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9&version=9) (`dailymed-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide DailyMed SPL version 9." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#dailymed-label-setmelanotide-70c3ccf7-4df0-4c75-ba07-fede9970c8d9-v9-v1 SHA-256: 3375ec62598fed729a98734dd642c763ceb5c6301d3cc3c5d18897f8c2c362f6.

---

<a id="fda-drugs-nda213793-v1"></a>

## Drugs@FDA application NDA213793

> The official Drugs@FDA dataset lists original submission 1 for NDA 213793 with status AP dated 2020-11-25, and names setmelanotide acetate among the application record's active ingredients.

- Evidence object: `story:fda-drugs-nda213793:v1`
- Evidence domain: Regulatory
- Date in source: 2020-11-25
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/fda-drugs-nda213793/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#fda-drugs-nda213793-v1
- Content SHA-256: `75fe2e7d41932b4c2e81c4f2aa7d98d74813d19d46537af63043fcbead3065a5`

### Claims and source pins

#### Headline

Drugs@FDA application NDA213793 ([`fda-drugs-nda213793-2020-11-25-5c2792fff70d`](#source-fda-drugs-nda213793-2020-11-25-5c2792fff70d))

#### Summary

The official Drugs@FDA dataset lists original submission 1 for NDA 213793 with status AP dated 2020-11-25, and names setmelanotide acetate among the application record's active ingredients. ([`fda-drugs-nda213793-2020-11-25-5c2792fff70d`](#source-fda-drugs-nda213793-2020-11-25-5c2792fff70d))

#### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for NDA 213793 with status AP dated 2020-11-25, and names setmelanotide acetate among the application record's active ingredients. ([`fda-drugs-nda213793-2020-11-25-5c2792fff70d`](#source-fda-drugs-nda213793-2020-11-25-5c2792fff70d))

#### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-nda213793-2020-11-25-5c2792fff70d`](#source-fda-drugs-nda213793-2020-11-25-5c2792fff70d))

### Sources

<a id="source-fda-drugs-nda213793-2020-11-25-5c2792fff70d"></a>
- **Drugs@FDA application NDA213793 · original submission status AP · 2020-11-25 · dataset 2026-08-13** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA213793%22&limit=1) (`fda-drugs-nda213793-2020-11-25-5c2792fff70d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Drugs@FDA application NDA213793." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#fda-drugs-nda213793-v1 SHA-256: 75fe2e7d41932b4c2e81c4f2aa7d98d74813d19d46537af63043fcbead3065a5.

---

<a id="federal-register-2020-27760-v1"></a>

## Federal Register notice 2020-27760

> The Federal Register published notice 2020-27760, attributed to FDA and its parent HHS department, on 2020-12-17. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

- Evidence object: `story:federal-register-2020-27760:v1`
- Evidence domain: Regulatory
- Date in source: 2020-12-17
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2020-27760/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#federal-register-2020-27760-v1
- Content SHA-256: `86b453eb68e9ce6a3bc800fb46654e3de0d95551fa0b83f6b74d12da1c15ba53`

### Claims and source pins

#### Headline

Federal Register notice 2020-27760 ([`federal-register-2020-27760-e9cb7dd8f57e`](#source-federal-register-2020-27760-e9cb7dd8f57e))

#### Summary

The Federal Register published notice 2020-27760, attributed to FDA and its parent HHS department, on 2020-12-17. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide. ([`federal-register-2020-27760-e9cb7dd8f57e`](#source-federal-register-2020-27760-e9cb7dd8f57e))

#### Paragraph 1

The Federal Register published notice 2020-27760, attributed to FDA and its parent HHS department, on 2020-12-17. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide. ([`federal-register-2020-27760-e9cb7dd8f57e`](#source-federal-register-2020-27760-e9cb7dd8f57e))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2020-27760-e9cb7dd8f57e`](#source-federal-register-2020-27760-e9cb7dd8f57e))

### Sources

<a id="source-federal-register-2020-27760-e9cb7dd8f57e"></a>
- **Federal Register notice 2020-27760 · published 2020-12-17 · Issuance of Priority Review Voucher; Rare Pediatric Disease Product** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2020-12-17/pdf/2020-27760.pdf) (`federal-register-2020-27760-e9cb7dd8f57e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2020-27760." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#federal-register-2020-27760-v1 SHA-256: 86b453eb68e9ce6a3bc800fb46654e3de0d95551fa0b83f6b74d12da1c15ba53.

---

<a id="federal-register-2022-14134-v1"></a>

## Federal Register notice 2022-14134

> The Federal Register published notice 2022-14134, attributed to FDA and its parent HHS department, on 2022-07-01. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; IMCIVREE,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

- Evidence object: `story:federal-register-2022-14134:v1`
- Evidence domain: Regulatory
- Date in source: 2022-07-01
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2022-14134/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#federal-register-2022-14134-v1
- Content SHA-256: `96482e108dc61c05a1835608adc60d8d2b118c0f40f6187b02e916df272ed23c`

### Claims and source pins

#### Headline

Federal Register notice 2022-14134 ([`federal-register-2022-14134-524250272982`](#source-federal-register-2022-14134-524250272982))

#### Summary

The Federal Register published notice 2022-14134, attributed to FDA and its parent HHS department, on 2022-07-01. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; IMCIVREE,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide. ([`federal-register-2022-14134-524250272982`](#source-federal-register-2022-14134-524250272982))

#### Paragraph 1

The Federal Register published notice 2022-14134, attributed to FDA and its parent HHS department, on 2022-07-01. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; IMCIVREE,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide. ([`federal-register-2022-14134-524250272982`](#source-federal-register-2022-14134-524250272982))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2022-14134-524250272982`](#source-federal-register-2022-14134-524250272982))

### Sources

<a id="source-federal-register-2022-14134-524250272982"></a>
- **Federal Register notice 2022-14134 · published 2022-07-01 · Determination of Regulatory Review Period for Purposes of Patent Extension; IMCIVREE** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2022-07-01/pdf/2022-14134.pdf) (`federal-register-2022-14134-524250272982`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2022-14134." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#federal-register-2022-14134-v1 SHA-256: 96482e108dc61c05a1835608adc60d8d2b118c0f40f6187b02e916df272ed23c.

---

<a id="federal-register-2022-16502-v1"></a>

## Federal Register notice 2022-16502

> The Federal Register published notice 2022-16502, attributed to FDA and its parent HHS department, on 2022-08-03. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

- Evidence object: `story:federal-register-2022-16502:v1`
- Evidence domain: Regulatory
- Date in source: 2022-08-03
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2022-16502/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#federal-register-2022-16502-v1
- Content SHA-256: `67d96bff22e49998a02eb46f1989464a2dd4c58c0885094fa05f47d652c41947`

### Claims and source pins

#### Headline

Federal Register notice 2022-16502 ([`federal-register-2022-16502-a32e87628979`](#source-federal-register-2022-16502-a32e87628979))

#### Summary

The Federal Register published notice 2022-16502, attributed to FDA and its parent HHS department, on 2022-08-03. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide. ([`federal-register-2022-16502-a32e87628979`](#source-federal-register-2022-16502-a32e87628979))

#### Paragraph 1

The Federal Register published notice 2022-16502, attributed to FDA and its parent HHS department, on 2022-08-03. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide. ([`federal-register-2022-16502-a32e87628979`](#source-federal-register-2022-16502-a32e87628979))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2022-16502-a32e87628979`](#source-federal-register-2022-16502-a32e87628979))

### Sources

<a id="source-federal-register-2022-16502-a32e87628979"></a>
- **Federal Register notice 2022-16502 · published 2022-08-03 · Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2022-08-03/pdf/2022-16502.pdf) (`federal-register-2022-16502-a32e87628979`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2022-16502." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#federal-register-2022-16502-v1 SHA-256: 67d96bff22e49998a02eb46f1989464a2dd4c58c0885094fa05f47d652c41947.

---

<a id="federal-register-2026-07863-v1"></a>

## Federal Register rule 2026-07863

> The Federal Register published rule 2026-07863, attributed to FDA and its parent HHS department, on 2026-04-22. Its official title is “Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

- Evidence object: `story:federal-register-2026-07863:v1`
- Evidence domain: Regulatory
- Date in source: 2026-04-22
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2026-07863/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#federal-register-2026-07863-v1
- Content SHA-256: `f5e0063065eea83f36f362b2015d3e6f4a47e18216268629e5b454711664000e`

### Claims and source pins

#### Headline

Federal Register rule 2026-07863 ([`federal-register-2026-07863-35bd6782c101`](#source-federal-register-2026-07863-35bd6782c101))

#### Summary

The Federal Register published rule 2026-07863, attributed to FDA and its parent HHS department, on 2026-04-22. Its official title is “Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide. ([`federal-register-2026-07863-35bd6782c101`](#source-federal-register-2026-07863-35bd6782c101))

#### Paragraph 1

The Federal Register published rule 2026-07863, attributed to FDA and its parent HHS department, on 2026-04-22. Its official title is “Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide. ([`federal-register-2026-07863-35bd6782c101`](#source-federal-register-2026-07863-35bd6782c101))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2026-07863-35bd6782c101`](#source-federal-register-2026-07863-35bd6782c101))

### Sources

<a id="source-federal-register-2026-07863-35bd6782c101"></a>
- **Federal Register rule 2026-07863 · published 2026-04-22 · Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2026-04-22/pdf/2026-07863.pdf) (`federal-register-2026-07863-35bd6782c101`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register rule 2026-07863." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#federal-register-2026-07863-v1 SHA-256: f5e0063065eea83f36f362b2015d3e6f4a47e18216268629e5b454711664000e.

---

<a id="pubmed-pmid-27339818-setmelanotide-v1"></a>

## Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist.

> PubMed lists PMID 27339818 in British journal of pharmacology as Journal Article, with publication-date metadata of 2016-07-27 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-27339818-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27339818-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-27339818-setmelanotide-v1
- Content SHA-256: `8f8c508de6688c0ebb9df7a60bf0d0222e576a933cebb92b5bcfd5d082543853`

### Claims and source pins

#### Headline

Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist. ([`pubmed-observation-pmid-27339818-2026-01-27-a29f3e7ebcd0`](#source-pubmed-observation-pmid-27339818-2026-01-27-a29f3e7ebcd0))

#### Summary

PubMed lists PMID 27339818 in British journal of pharmacology as Journal Article, with publication-date metadata of 2016-07-27 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27339818-2026-01-27-a29f3e7ebcd0`](#source-pubmed-observation-pmid-27339818-2026-01-27-a29f3e7ebcd0))

#### Paragraph 1

PubMed lists PMID 27339818 in British journal of pharmacology as Journal Article, with publication-date metadata of 2016-07-27 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27339818-2026-01-27-a29f3e7ebcd0`](#source-pubmed-observation-pmid-27339818-2026-01-27-a29f3e7ebcd0))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27339818-2026-01-27-a29f3e7ebcd0`](#source-pubmed-observation-pmid-27339818-2026-01-27-a29f3e7ebcd0))

### Sources

<a id="source-pubmed-observation-pmid-27339818-2026-01-27-a29f3e7ebcd0"></a>
- **Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist. · retained source version 1:2026-01-27:current:a29f3e7ebcd07af44da035dc31ca80409801728d1ead481051545d9669542a1f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27339818/) (`pubmed-observation-pmid-27339818-2026-01-27-a29f3e7ebcd0`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-27339818-setmelanotide-v1 SHA-256: 8f8c508de6688c0ebb9df7a60bf0d0222e576a933cebb92b5bcfd5d082543853.

---

<a id="pubmed-pmid-29031731-setmelanotide-v1"></a>

## Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.

> PubMed lists PMID 29031731 in Molecular metabolism as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-07-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-29031731-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-05-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29031731-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-29031731-setmelanotide-v1
- Content SHA-256: `1a4bd4dc4c91403d19e4f597e7da33dda53108e267a7683d761641295dbb8232`

### Claims and source pins

#### Headline

Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency. ([`pubmed-observation-pmid-29031731-2025-05-30-e20430e891ff`](#source-pubmed-observation-pmid-29031731-2025-05-30-e20430e891ff))

#### Summary

PubMed lists PMID 29031731 in Molecular metabolism as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-07-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29031731-2025-05-30-e20430e891ff`](#source-pubmed-observation-pmid-29031731-2025-05-30-e20430e891ff))

#### Paragraph 1

PubMed lists PMID 29031731 in Molecular metabolism as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-07-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29031731-2025-05-30-e20430e891ff`](#source-pubmed-observation-pmid-29031731-2025-05-30-e20430e891ff))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29031731-2025-05-30-e20430e891ff`](#source-pubmed-observation-pmid-29031731-2025-05-30-e20430e891ff))

### Sources

<a id="source-pubmed-observation-pmid-29031731-2025-05-30-e20430e891ff"></a>
- **Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency. · retained source version 1:2025-05-30:current:e20430e891ff10382af4da2df9e9bdfb7d1c82a7419ba40af212806934dc1d6e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29031731/) (`pubmed-observation-pmid-29031731-2025-05-30-e20430e891ff`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-29031731-setmelanotide-v1 SHA-256: 1a4bd4dc4c91403d19e4f597e7da33dda53108e267a7683d761641295dbb8232.

---

<a id="pubmed-pmid-32213649-setmelanotide-v1"></a>

## PubMed record PMID 32213649

> PeptideScanner retained PubMed bibliographic metadata for PMID 32213649 at 2026-08-10T18:13:32.288Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2020-03-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-32213649-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-10
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-32213649-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-32213649-setmelanotide-v1
- Content SHA-256: `a78da956f72baa60babae1a9a78c4a223bfc480f57c65b3131fb05f7b4c77de4`

### Claims and source pins

#### Headline

PubMed record PMID 32213649 ([`pubmed-observation-pmid-32213649-2026-07-10-13e016b13870`](#source-pubmed-observation-pmid-32213649-2026-07-10-13e016b13870))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 32213649 at 2026-08-10T18:13:32.288Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2020-03-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-32213649-2026-07-10-13e016b13870`](#source-pubmed-observation-pmid-32213649-2026-07-10-13e016b13870))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 32213649 at 2026-08-10T18:13:32.288Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2020-03-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-32213649-2026-07-10-13e016b13870`](#source-pubmed-observation-pmid-32213649-2026-07-10-13e016b13870))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-32213649-2026-07-10-13e016b13870`](#source-pubmed-observation-pmid-32213649-2026-07-10-13e016b13870))

### Sources

<a id="source-pubmed-observation-pmid-32213649-2026-07-10-13e016b13870"></a>
- **PubMed record PMID 32213649 · retained source version 1:2026-07-10:current:13e016b13870ae4715dbfbbc195569889e99dfca427a294e7cc9c169e7eb6607** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/32213649/) (`pubmed-observation-pmid-32213649-2026-07-10-13e016b13870`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 32213649." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-32213649-setmelanotide-v1 SHA-256: a78da956f72baa60babae1a9a78c4a223bfc480f57c65b3131fb05f7b4c77de4.

---

<a id="pubmed-pmid-33137293-setmelanotide-v1"></a>

## PubMed record PMID 33137293

> PeptideScanner retained PubMed bibliographic metadata for PMID 33137293 at 2026-07-30T16:20:34.542Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2020-11-02. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-33137293-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-33137293-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-33137293-setmelanotide-v1
- Content SHA-256: `107ca9655cee9bfdfb493c424ae5d93510ca85eed4417ee41181a409fe9bbc5f`

### Claims and source pins

#### Headline

PubMed record PMID 33137293 ([`pubmed-observation-pmid-33137293-2026-05-18-2ae68eb49348`](#source-pubmed-observation-pmid-33137293-2026-05-18-2ae68eb49348))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 33137293 at 2026-07-30T16:20:34.542Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2020-11-02. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-33137293-2026-05-18-2ae68eb49348`](#source-pubmed-observation-pmid-33137293-2026-05-18-2ae68eb49348))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 33137293 at 2026-07-30T16:20:34.542Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2020-11-02. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-33137293-2026-05-18-2ae68eb49348`](#source-pubmed-observation-pmid-33137293-2026-05-18-2ae68eb49348))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-33137293-2026-05-18-2ae68eb49348`](#source-pubmed-observation-pmid-33137293-2026-05-18-2ae68eb49348))

### Sources

<a id="source-pubmed-observation-pmid-33137293-2026-05-18-2ae68eb49348"></a>
- **PubMed record PMID 33137293 · retained source version 1:2026-05-18:current:2ae68eb49348ba26d92a3fead043f673ba8338e2091b69dcc69463d4d0c73465** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/33137293/) (`pubmed-observation-pmid-33137293-2026-05-18-2ae68eb49348`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 33137293." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-33137293-setmelanotide-v1 SHA-256: 107ca9655cee9bfdfb493c424ae5d93510ca85eed4417ee41181a409fe9bbc5f.

---

<a id="pubmed-pmid-33137294-setmelanotide-v1"></a>

## Setmelanotide: what does it mean for clinical care of patients with obesity?

> PubMed lists PMID 33137294 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2020-10-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-33137294-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-07-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-33137294-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-33137294-setmelanotide-v1
- Content SHA-256: `14cb915936a531d69a13b0f339952cee4399da65cee03759b6647d726a9dbe8c`

### Claims and source pins

#### Headline

Setmelanotide: what does it mean for clinical care of patients with obesity? ([`pubmed-observation-pmid-33137294-2021-07-21-787ee1ec4390`](#source-pubmed-observation-pmid-33137294-2021-07-21-787ee1ec4390))

#### Summary

PubMed lists PMID 33137294 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2020-10-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33137294-2021-07-21-787ee1ec4390`](#source-pubmed-observation-pmid-33137294-2021-07-21-787ee1ec4390))

#### Paragraph 1

PubMed lists PMID 33137294 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2020-10-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33137294-2021-07-21-787ee1ec4390`](#source-pubmed-observation-pmid-33137294-2021-07-21-787ee1ec4390))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-33137294-2021-07-21-787ee1ec4390`](#source-pubmed-observation-pmid-33137294-2021-07-21-787ee1ec4390))

### Sources

<a id="source-pubmed-observation-pmid-33137294-2021-07-21-787ee1ec4390"></a>
- **Setmelanotide: what does it mean for clinical care of patients with obesity? · retained source version 1:2021-07-21:current:787ee1ec4390f50b27dc66b9d0a2de6ee71aeb6d9dc5188e77ef1abd17469d79** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/33137294/) (`pubmed-observation-pmid-33137294-2021-07-21-787ee1ec4390`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide: what does it mean for clinical care of patients with obesity?" Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-33137294-setmelanotide-v1 SHA-256: 14cb915936a531d69a13b0f339952cee4399da65cee03759b6647d726a9dbe8c.

---

<a id="pubmed-pmid-33638809-setmelanotide-v1"></a>

## Setmelanotide: First Approval.

> PubMed lists PMID 33638809 in Drugs as Journal Article, Review, with publication-date metadata of 2021-02 (month precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-33638809-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-10-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-33638809-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-33638809-setmelanotide-v1
- Content SHA-256: `88cffb6fd95a411908968fdfa8e8038c277e27075b784d0e6675ee7612013ab2`

### Claims and source pins

#### Headline

Setmelanotide: First Approval. ([`pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8`](#source-pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8))

#### Summary

PubMed lists PMID 33638809 in Drugs as Journal Article, Review, with publication-date metadata of 2021-02 (month precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8`](#source-pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8))

#### Paragraph 1

PubMed lists PMID 33638809 in Drugs as Journal Article, Review, with publication-date metadata of 2021-02 (month precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8`](#source-pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8`](#source-pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8))

### Sources

<a id="source-pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8"></a>
- **Setmelanotide: First Approval. · retained source version 1:2021-10-11:current:afa3d97ef8b8c9f411fecf06faee8e28eec64902803b9da85eb39f413fe7b596** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/33638809/) (`pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide: First Approval." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-33638809-setmelanotide-v1 SHA-256: 88cffb6fd95a411908968fdfa8e8038c277e27075b784d0e6675ee7612013ab2.

---

<a id="pubmed-pmid-33787829-setmelanotide-v1"></a>

## Setmelanotide Acetate.

> PubMed lists PMID 33787829 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2021-03-31 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-33787829-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-09-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-33787829-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-33787829-setmelanotide-v1
- Content SHA-256: `d9586698551905b9c598d2939154ca8c5ff48c67e9644fc1a0537f99815d25a0`

### Claims and source pins

#### Headline

Setmelanotide Acetate. ([`pubmed-observation-pmid-33787829-2021-09-29-370a1d7711c1`](#source-pubmed-observation-pmid-33787829-2021-09-29-370a1d7711c1))

#### Summary

PubMed lists PMID 33787829 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2021-03-31 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33787829-2021-09-29-370a1d7711c1`](#source-pubmed-observation-pmid-33787829-2021-09-29-370a1d7711c1))

#### Paragraph 1

PubMed lists PMID 33787829 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2021-03-31 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33787829-2021-09-29-370a1d7711c1`](#source-pubmed-observation-pmid-33787829-2021-09-29-370a1d7711c1))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-33787829-2021-09-29-370a1d7711c1`](#source-pubmed-observation-pmid-33787829-2021-09-29-370a1d7711c1))

### Sources

<a id="source-pubmed-observation-pmid-33787829-2021-09-29-370a1d7711c1"></a>
- **Setmelanotide Acetate. · retained source version 1:2021-09-29:current:370a1d7711c193d63447357a8c06f5891673c8b04936838027131b8f9fa6c8ad** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/33787829/) (`pubmed-observation-pmid-33787829-2021-09-29-370a1d7711c1`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide Acetate." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-33787829-setmelanotide-v1 SHA-256: d9586698551905b9c598d2939154ca8c5ff48c67e9644fc1a0537f99815d25a0.

---

<a id="pubmed-pmid-34544109-setmelanotide-v1"></a>

## Setmelanotide (Imcivree) for rare genetic forms of obesity.

> PubMed lists PMID 34544109 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2021-07-26 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34544109-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-09-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34544109-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-34544109-setmelanotide-v1
- Content SHA-256: `49e9dd397f5f951a72aa1ccddcaf1ae861acbe9f76e4e3e6b3065d39f0a33a66`

### Claims and source pins

#### Headline

Setmelanotide (Imcivree) for rare genetic forms of obesity. ([`pubmed-observation-pmid-34544109-2021-09-28-916f0e404042`](#source-pubmed-observation-pmid-34544109-2021-09-28-916f0e404042))

#### Summary

PubMed lists PMID 34544109 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2021-07-26 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34544109-2021-09-28-916f0e404042`](#source-pubmed-observation-pmid-34544109-2021-09-28-916f0e404042))

#### Paragraph 1

PubMed lists PMID 34544109 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2021-07-26 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34544109-2021-09-28-916f0e404042`](#source-pubmed-observation-pmid-34544109-2021-09-28-916f0e404042))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34544109-2021-09-28-916f0e404042`](#source-pubmed-observation-pmid-34544109-2021-09-28-916f0e404042))

### Sources

<a id="source-pubmed-observation-pmid-34544109-2021-09-28-916f0e404042"></a>
- **Setmelanotide (Imcivree) for rare genetic forms of obesity. · retained source version 1:2021-09-28:current:916f0e404042939b035f3cabb3bb7fc592001cc3ea454a2362c6be24e22babea** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34544109/) (`pubmed-observation-pmid-34544109-2021-09-28-916f0e404042`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide (Imcivree) for rare genetic forms of obesity." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-34544109-setmelanotide-v1 SHA-256: 49e9dd397f5f951a72aa1ccddcaf1ae861acbe9f76e4e3e6b3065d39f0a33a66.

---

<a id="pubmed-pmid-34561620-setmelanotide-v1"></a>

## PubMed record PMID 34561620

> PeptideScanner retained PubMed bibliographic metadata for PMID 34561620 at 2026-07-30T16:14:06.776Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2021-09-25. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-34561620-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34561620-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-34561620-setmelanotide-v1
- Content SHA-256: `3ee9b95d267a6cf520dad7e30c3add2805c0cd36b47836dd16611c877c0117ce`

### Claims and source pins

#### Headline

PubMed record PMID 34561620 ([`pubmed-observation-pmid-34561620-2026-06-08-bead05d85606`](#source-pubmed-observation-pmid-34561620-2026-06-08-bead05d85606))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 34561620 at 2026-07-30T16:14:06.776Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2021-09-25. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-34561620-2026-06-08-bead05d85606`](#source-pubmed-observation-pmid-34561620-2026-06-08-bead05d85606))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 34561620 at 2026-07-30T16:14:06.776Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2021-09-25. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-34561620-2026-06-08-bead05d85606`](#source-pubmed-observation-pmid-34561620-2026-06-08-bead05d85606))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34561620-2026-06-08-bead05d85606`](#source-pubmed-observation-pmid-34561620-2026-06-08-bead05d85606))

### Sources

<a id="source-pubmed-observation-pmid-34561620-2026-06-08-bead05d85606"></a>
- **PubMed record PMID 34561620 · retained source version 1:2026-06-08:current:bead05d85606978f91edc8c9de1f663a12e64242656422f5d9dce0cbd28c320e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34561620/) (`pubmed-observation-pmid-34561620-2026-06-08-bead05d85606`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 34561620." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-34561620-setmelanotide-v1 SHA-256: 3ee9b95d267a6cf520dad7e30c3add2805c0cd36b47836dd16611c877c0117ce.

---

<a id="pubmed-pmid-35931197-setmelanotide-v1"></a>

## Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.

> PubMed lists PMID 35931197 in Life sciences as Journal Article, with publication-date metadata of 2022-08-02 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-35931197-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-10-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-35931197-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-35931197-setmelanotide-v1
- Content SHA-256: `44fee896fa1159223f45df09a8f0994519afb48f14efc51c28687d059c07e1c4`

### Claims and source pins

#### Headline

Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor. ([`pubmed-observation-pmid-35931197-2022-10-14-6fd161d3c389`](#source-pubmed-observation-pmid-35931197-2022-10-14-6fd161d3c389))

#### Summary

PubMed lists PMID 35931197 in Life sciences as Journal Article, with publication-date metadata of 2022-08-02 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35931197-2022-10-14-6fd161d3c389`](#source-pubmed-observation-pmid-35931197-2022-10-14-6fd161d3c389))

#### Paragraph 1

PubMed lists PMID 35931197 in Life sciences as Journal Article, with publication-date metadata of 2022-08-02 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35931197-2022-10-14-6fd161d3c389`](#source-pubmed-observation-pmid-35931197-2022-10-14-6fd161d3c389))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-35931197-2022-10-14-6fd161d3c389`](#source-pubmed-observation-pmid-35931197-2022-10-14-6fd161d3c389))

### Sources

<a id="source-pubmed-observation-pmid-35931197-2022-10-14-6fd161d3c389"></a>
- **Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor. · retained source version 1:2022-10-14:current:6fd161d3c3895b07649d0e651156a67a67a8653466609e25db6a65bc9deeb9a7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/35931197/) (`pubmed-observation-pmid-35931197-2022-10-14-6fd161d3c389`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-35931197-setmelanotide-v1 SHA-256: 44fee896fa1159223f45df09a8f0994519afb48f14efc51c28687d059c07e1c4.

---

<a id="pubmed-pmid-38567654-setmelanotide-v1"></a>

## PubMed record PMID 38567654

> PeptideScanner retained PubMed bibliographic metadata for PMID 38567654 at 2026-08-10T18:13:32.350Z. PubMed recorded a metadata revision date of 2026-07-04 and an Entrez history date of 2024-04-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38567654-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-04
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38567654-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-38567654-setmelanotide-v1
- Content SHA-256: `38b52940eb5c0f2a146f3c98b03b189a579d99ee37aff961c36321f5281082db`

### Claims and source pins

#### Headline

PubMed record PMID 38567654 ([`pubmed-observation-pmid-38567654-2026-07-04-34d87f881b9d`](#source-pubmed-observation-pmid-38567654-2026-07-04-34d87f881b9d))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38567654 at 2026-08-10T18:13:32.350Z. PubMed recorded a metadata revision date of 2026-07-04 and an Entrez history date of 2024-04-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38567654-2026-07-04-34d87f881b9d`](#source-pubmed-observation-pmid-38567654-2026-07-04-34d87f881b9d))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38567654 at 2026-08-10T18:13:32.350Z. PubMed recorded a metadata revision date of 2026-07-04 and an Entrez history date of 2024-04-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38567654-2026-07-04-34d87f881b9d`](#source-pubmed-observation-pmid-38567654-2026-07-04-34d87f881b9d))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38567654-2026-07-04-34d87f881b9d`](#source-pubmed-observation-pmid-38567654-2026-07-04-34d87f881b9d))

### Sources

<a id="source-pubmed-observation-pmid-38567654-2026-07-04-34d87f881b9d"></a>
- **PubMed record PMID 38567654 · retained source version 1:2026-07-04:current:34d87f881b9d8420d744147fb1d91aca5827e6e0a165ac37ef86d11da261fcca** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38567654/) (`pubmed-observation-pmid-38567654-2026-07-04-34d87f881b9d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38567654." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-38567654-setmelanotide-v1 SHA-256: 38b52940eb5c0f2a146f3c98b03b189a579d99ee37aff961c36321f5281082db.

---

<a id="pubmed-pmid-38697183-setmelanotide-v1"></a>

## Setmelanotide: new promise for the treatment of hypothalamic obesity?

> PubMed lists PMID 38697183 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38697183-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-05-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38697183-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-38697183-setmelanotide-v1
- Content SHA-256: `29c9db5a08d7e5a49fef50f36765d3666c12ee3f49546b242c37474fa64e5454`

### Claims and source pins

#### Headline

Setmelanotide: new promise for the treatment of hypothalamic obesity? ([`pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f`](#source-pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f))

#### Summary

PubMed lists PMID 38697183 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f`](#source-pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f))

#### Paragraph 1

PubMed lists PMID 38697183 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f`](#source-pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f`](#source-pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f))

### Sources

<a id="source-pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f"></a>
- **Setmelanotide: new promise for the treatment of hypothalamic obesity? · retained source version 1:2025-05-21:current:6efa835d669fa42cb097c158573de2ee5fdf145a928c986a5edc7f8e1d36510c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38697183/) (`pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide: new promise for the treatment of hypothalamic obesity?" Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-38697183-setmelanotide-v1 SHA-256: 29c9db5a08d7e5a49fef50f36765d3666c12ee3f49546b242c37474fa64e5454.

---

<a id="pubmed-pmid-38697184-setmelanotide-v1"></a>

## Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial.

> PubMed lists PMID 38697184 in The lancet. Diabetes & endocrinology as Journal Article, Clinical Trial, Phase II, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38697184-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-05-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38697184-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-38697184-setmelanotide-v1
- Content SHA-256: `2a232eb933838734696a2210181e3a2fc75ef23ba94f5b62b40441603eb08790`

### Claims and source pins

#### Headline

Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial. ([`pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b`](#source-pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b))

#### Summary

PubMed lists PMID 38697184 in The lancet. Diabetes & endocrinology as Journal Article, Clinical Trial, Phase II, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b`](#source-pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b))

#### Paragraph 1

PubMed lists PMID 38697184 in The lancet. Diabetes & endocrinology as Journal Article, Clinical Trial, Phase II, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b`](#source-pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b`](#source-pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b))

### Sources

<a id="source-pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b"></a>
- **Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial. · retained source version 1:2025-05-21:current:486d47792a4b58d582a695ac80e7fda867c70c8c71e0782d257403cda7cc77fc** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38697184/) (`pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-38697184-setmelanotide-v1 SHA-256: 2a232eb933838734696a2210181e3a2fc75ef23ba94f5b62b40441603eb08790.

---

<a id="pubmed-pmid-38987029-setmelanotide-v1"></a>

## PubMed record PMID 38987029

> PeptideScanner retained PubMed bibliographic metadata for PMID 38987029 at 2026-07-30T16:22:12.162Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2024-07-10. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38987029-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38987029-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-38987029-setmelanotide-v1
- Content SHA-256: `f1725bc76f49b575abdc514f825ba64f29c1f2f5f34446915cf16aa7712ad650`

### Claims and source pins

#### Headline

PubMed record PMID 38987029 ([`pubmed-observation-pmid-38987029-2026-04-17-c18ce8ea8066`](#source-pubmed-observation-pmid-38987029-2026-04-17-c18ce8ea8066))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38987029 at 2026-07-30T16:22:12.162Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2024-07-10. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38987029-2026-04-17-c18ce8ea8066`](#source-pubmed-observation-pmid-38987029-2026-04-17-c18ce8ea8066))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38987029 at 2026-07-30T16:22:12.162Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2024-07-10. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38987029-2026-04-17-c18ce8ea8066`](#source-pubmed-observation-pmid-38987029-2026-04-17-c18ce8ea8066))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38987029-2026-04-17-c18ce8ea8066`](#source-pubmed-observation-pmid-38987029-2026-04-17-c18ce8ea8066))

### Sources

<a id="source-pubmed-observation-pmid-38987029-2026-04-17-c18ce8ea8066"></a>
- **PubMed record PMID 38987029 · retained source version 1:2026-04-17:current:c18ce8ea8066acf64cf33bcdf45b90a196c1430323a66b7f3dd31450a9c753fb** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38987029/) (`pubmed-observation-pmid-38987029-2026-04-17-c18ce8ea8066`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38987029." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-38987029-setmelanotide-v1 SHA-256: f1725bc76f49b575abdc514f825ba64f29c1f2f5f34446915cf16aa7712ad650.

---

<a id="pubmed-pmid-39284294-setmelanotide-v1"></a>

## PubMed record PMID 39284294

> PeptideScanner retained PubMed bibliographic metadata for PMID 39284294 at 2026-07-30T16:22:15.952Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2024-09-16. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39284294-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39284294-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-39284294-setmelanotide-v1
- Content SHA-256: `2ea61aff86c764cce78fa5d5eb7607f7607c14ad6f5a9cab876ee71b5f01d2d9`

### Claims and source pins

#### Headline

PubMed record PMID 39284294 ([`pubmed-observation-pmid-39284294-2026-04-17-17bb6aa537e7`](#source-pubmed-observation-pmid-39284294-2026-04-17-17bb6aa537e7))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39284294 at 2026-07-30T16:22:15.952Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2024-09-16. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39284294-2026-04-17-17bb6aa537e7`](#source-pubmed-observation-pmid-39284294-2026-04-17-17bb6aa537e7))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39284294 at 2026-07-30T16:22:15.952Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2024-09-16. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39284294-2026-04-17-17bb6aa537e7`](#source-pubmed-observation-pmid-39284294-2026-04-17-17bb6aa537e7))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39284294-2026-04-17-17bb6aa537e7`](#source-pubmed-observation-pmid-39284294-2026-04-17-17bb6aa537e7))

### Sources

<a id="source-pubmed-observation-pmid-39284294-2026-04-17-17bb6aa537e7"></a>
- **PubMed record PMID 39284294 · retained source version 1:2026-04-17:current:17bb6aa537e70fe6ab124bf54f6c53398316a18bc9dd2e1837e73d4b79a32a18** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39284294/) (`pubmed-observation-pmid-39284294-2026-04-17-17bb6aa537e7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39284294." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-39284294-setmelanotide-v1 SHA-256: 2ea61aff86c764cce78fa5d5eb7607f7607c14ad6f5a9cab876ee71b5f01d2d9.

---

<a id="pubmed-pmid-39394922-setmelanotide-v1"></a>

## Carbocyclic setmelanotide analogs maintain biochemical potency at melanocortin 4 receptors.

> PubMed lists PMID 39394922 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, with publication-date metadata of 2024-10-12 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39394922-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-11-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39394922-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-39394922-setmelanotide-v1
- Content SHA-256: `6785852ab5a541f26cbad5f39ec2a0f74db140c2515407c67a1c3df74da17772`

### Claims and source pins

#### Headline

Carbocyclic setmelanotide analogs maintain biochemical potency at melanocortin 4 receptors. ([`pubmed-observation-pmid-39394922-2025-11-19-868fff9ba5da`](#source-pubmed-observation-pmid-39394922-2025-11-19-868fff9ba5da))

#### Summary

PubMed lists PMID 39394922 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, with publication-date metadata of 2024-10-12 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39394922-2025-11-19-868fff9ba5da`](#source-pubmed-observation-pmid-39394922-2025-11-19-868fff9ba5da))

#### Paragraph 1

PubMed lists PMID 39394922 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, with publication-date metadata of 2024-10-12 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39394922-2025-11-19-868fff9ba5da`](#source-pubmed-observation-pmid-39394922-2025-11-19-868fff9ba5da))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39394922-2025-11-19-868fff9ba5da`](#source-pubmed-observation-pmid-39394922-2025-11-19-868fff9ba5da))

### Sources

<a id="source-pubmed-observation-pmid-39394922-2025-11-19-868fff9ba5da"></a>
- **Carbocyclic setmelanotide analogs maintain biochemical potency at melanocortin 4 receptors. · retained source version 1:2025-11-19:current:868fff9ba5dac266e6c60097c2efbec0c71892b5b786288efdac53400582dee1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39394922/) (`pubmed-observation-pmid-39394922-2025-11-19-868fff9ba5da`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Carbocyclic setmelanotide analogs maintain biochemical potency at melanocortin 4 receptors." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-39394922-setmelanotide-v1 SHA-256: 6785852ab5a541f26cbad5f39ec2a0f74db140c2515407c67a1c3df74da17772.

---

<a id="pubmed-pmid-39526054-setmelanotide-v1"></a>

## Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction.

> PubMed lists PMID 39526054 in TouchREVIEWS in endocrinology as Journal Article, Review, with publication-date metadata of 2024-02-09 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39526054-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39526054-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-39526054-setmelanotide-v1
- Content SHA-256: `38800739600e434ba0cfedb73a5fad73493c766539104b78f06cbabd32cec126`

### Claims and source pins

#### Headline

Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction. ([`pubmed-observation-pmid-39526054-2024-11-21-a62ab4e03e3d`](#source-pubmed-observation-pmid-39526054-2024-11-21-a62ab4e03e3d))

#### Summary

PubMed lists PMID 39526054 in TouchREVIEWS in endocrinology as Journal Article, Review, with publication-date metadata of 2024-02-09 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39526054-2024-11-21-a62ab4e03e3d`](#source-pubmed-observation-pmid-39526054-2024-11-21-a62ab4e03e3d))

#### Paragraph 1

PubMed lists PMID 39526054 in TouchREVIEWS in endocrinology as Journal Article, Review, with publication-date metadata of 2024-02-09 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39526054-2024-11-21-a62ab4e03e3d`](#source-pubmed-observation-pmid-39526054-2024-11-21-a62ab4e03e3d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39526054-2024-11-21-a62ab4e03e3d`](#source-pubmed-observation-pmid-39526054-2024-11-21-a62ab4e03e3d))

### Sources

<a id="source-pubmed-observation-pmid-39526054-2024-11-21-a62ab4e03e3d"></a>
- **Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction. · retained source version 1:2024-11-21:current:a62ab4e03e3df4800537cd2efd1f5f2fde4fe82119d9454f331541a32db0c2de** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39526054/) (`pubmed-observation-pmid-39526054-2024-11-21-a62ab4e03e3d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-39526054-setmelanotide-v1 SHA-256: 38800739600e434ba0cfedb73a5fad73493c766539104b78f06cbabd32cec126.

---

<a id="pubmed-pmid-39549717-setmelanotide-v1"></a>

## Setmelanotide for the treatment of severe early-childhood genetic obesity.

> PubMed lists PMID 39549717 in The lancet. Diabetes & endocrinology as Journal Article, with publication-date metadata of 2024-11-13 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39549717-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-12-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39549717-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-39549717-setmelanotide-v1
- Content SHA-256: `4eca3fff305f8c70f79df3ce54a07f18eb413ba44ce69efb78650a050965d6ea`

### Claims and source pins

#### Headline

Setmelanotide for the treatment of severe early-childhood genetic obesity. ([`pubmed-observation-pmid-39549717-2024-12-27-400f196b9bc1`](#source-pubmed-observation-pmid-39549717-2024-12-27-400f196b9bc1))

#### Summary

PubMed lists PMID 39549717 in The lancet. Diabetes & endocrinology as Journal Article, with publication-date metadata of 2024-11-13 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39549717-2024-12-27-400f196b9bc1`](#source-pubmed-observation-pmid-39549717-2024-12-27-400f196b9bc1))

#### Paragraph 1

PubMed lists PMID 39549717 in The lancet. Diabetes & endocrinology as Journal Article, with publication-date metadata of 2024-11-13 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39549717-2024-12-27-400f196b9bc1`](#source-pubmed-observation-pmid-39549717-2024-12-27-400f196b9bc1))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39549717-2024-12-27-400f196b9bc1`](#source-pubmed-observation-pmid-39549717-2024-12-27-400f196b9bc1))

### Sources

<a id="source-pubmed-observation-pmid-39549717-2024-12-27-400f196b9bc1"></a>
- **Setmelanotide for the treatment of severe early-childhood genetic obesity. · retained source version 1:2024-12-27:current:400f196b9bc1aaa495f22ac5999c4530ddd82645cd57b1e3f6239bd8c153742c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39549717/) (`pubmed-observation-pmid-39549717-2024-12-27-400f196b9bc1`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide for the treatment of severe early-childhood genetic obesity." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-39549717-setmelanotide-v1 SHA-256: 4eca3fff305f8c70f79df3ce54a07f18eb413ba44ce69efb78650a050965d6ea.

---

<a id="pubmed-pmid-40484968-setmelanotide-v1"></a>

## Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome.

> PubMed lists PMID 40484968 in Orphanet journal of rare diseases as Journal Article, with publication-date metadata of 2025-06-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40484968-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-06-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40484968-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-40484968-setmelanotide-v1
- Content SHA-256: `094632a4d33632d64cefdccccb3223ea086e4027d0abc4978851ec3a178fc47f`

### Claims and source pins

#### Headline

Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome. ([`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99`](#source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99))

#### Summary

PubMed lists PMID 40484968 in Orphanet journal of rare diseases as Journal Article, with publication-date metadata of 2025-06-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99`](#source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99))

#### Paragraph 1

PubMed lists PMID 40484968 in Orphanet journal of rare diseases as Journal Article, with publication-date metadata of 2025-06-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99`](#source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99`](#source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99))

### Sources

<a id="source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99"></a>
- **Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome. · retained source version 1:2025-06-11:current:ad972f169e992c541360bbf196f5a5a414536d4750243dfb1f1346e7d636f612** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40484968/) (`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-40484968-setmelanotide-v1 SHA-256: 094632a4d33632d64cefdccccb3223ea086e4027d0abc4978851ec3a178fc47f.

---

<a id="pubmed-pmid-40484968-setmelanotide-v2"></a>

## Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome.

> PubMed lists PMID 40484968 in Orphanet journal of rare diseases as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-06-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40484968-setmelanotide:v2`
- Evidence domain: Literature metadata
- Date in source: 2026-10-14
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40484968-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-40484968-setmelanotide-v2
- Content SHA-256: `9a2bb091fb6826fc431373f2af39db2be89a04d508b95bf270c38528091d357a`

### Claims and source pins

#### Headline

Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome. ([`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2`](#source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2))

#### Summary

PubMed lists PMID 40484968 in Orphanet journal of rare diseases as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-06-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2`](#source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2))

#### Paragraph 1

PubMed lists PMID 40484968 in Orphanet journal of rare diseases as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-06-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2`](#source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2`](#source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2))

### Sources

<a id="source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2"></a>
- **Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome. · retained source version 1:2026-10-14:current:f5608a0be290e78d9d8536f33363baab36cf27394a85aef4fb572f837a491b91** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40484968/) (`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2`)

### Correction lineage

updated on 2026-11-16: PubMed revised the bibliographic metadata of PMID 40484968, with a metadata revision date of 2026-10-14. This version reports that observation; the earlier retained observation remains available as version 1.
- Supersedes version: 1
- Correction sources: [`pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2`](#source-pubmed-observation-pmid-40484968-2025-06-11-ad972f169e99-r2)

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome." Version 2, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-40484968-setmelanotide-v2 SHA-256: 9a2bb091fb6826fc431373f2af39db2be89a04d508b95bf270c38528091d357a.

---

<a id="pubmed-pmid-40836563-setmelanotide-v1"></a>

## Development of Dysplastic Nevi in a Child with LEPR Deficiency Treated with Setmelanotide.

> PubMed lists PMID 40836563 in Journal of clinical research in pediatric endocrinology as Journal Article, with publication-date metadata of 2025-08-21 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40836563-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-08-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40836563-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-40836563-setmelanotide-v1
- Content SHA-256: `66841c36c4a39e609d2ad5d56644337ec367ee71b405e09bd7351191eaff4fed`

### Claims and source pins

#### Headline

Development of Dysplastic Nevi in a Child with LEPR Deficiency Treated with Setmelanotide. ([`pubmed-observation-pmid-40836563-2025-08-21-5724bc41941d`](#source-pubmed-observation-pmid-40836563-2025-08-21-5724bc41941d))

#### Summary

PubMed lists PMID 40836563 in Journal of clinical research in pediatric endocrinology as Journal Article, with publication-date metadata of 2025-08-21 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40836563-2025-08-21-5724bc41941d`](#source-pubmed-observation-pmid-40836563-2025-08-21-5724bc41941d))

#### Paragraph 1

PubMed lists PMID 40836563 in Journal of clinical research in pediatric endocrinology as Journal Article, with publication-date metadata of 2025-08-21 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40836563-2025-08-21-5724bc41941d`](#source-pubmed-observation-pmid-40836563-2025-08-21-5724bc41941d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40836563-2025-08-21-5724bc41941d`](#source-pubmed-observation-pmid-40836563-2025-08-21-5724bc41941d))

### Sources

<a id="source-pubmed-observation-pmid-40836563-2025-08-21-5724bc41941d"></a>
- **Development of Dysplastic Nevi in a Child with LEPR Deficiency Treated with Setmelanotide. · retained source version 1:2025-08-21:current:5724bc41941d0ddd22f5c7894d5b28b236c9ec68e6c426fb413660086b4889d6** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40836563/) (`pubmed-observation-pmid-40836563-2025-08-21-5724bc41941d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Development of Dysplastic Nevi in a Child with LEPR Deficiency Treated with Setmelanotide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-40836563-setmelanotide-v1 SHA-256: 66841c36c4a39e609d2ad5d56644337ec367ee71b405e09bd7351191eaff4fed.

---

<a id="pubmed-pmid-40903014-setmelanotide-v1"></a>

## PubMed record PMID 40903014

> PeptideScanner retained PubMed bibliographic metadata for PMID 40903014 at 2026-07-30T16:25:12.584Z. PubMed recorded a metadata revision date of 2026-02-19 and an Entrez history date of 2025-09-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40903014-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-02-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40903014-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-40903014-setmelanotide-v1
- Content SHA-256: `eb64ee6cc4d38dd5e8c0190165d027cb9bd3b76508403935885bbcf0883676e3`

### Claims and source pins

#### Headline

PubMed record PMID 40903014 ([`pubmed-observation-pmid-40903014-2026-02-19-30e5f2588ae8`](#source-pubmed-observation-pmid-40903014-2026-02-19-30e5f2588ae8))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40903014 at 2026-07-30T16:25:12.584Z. PubMed recorded a metadata revision date of 2026-02-19 and an Entrez history date of 2025-09-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40903014-2026-02-19-30e5f2588ae8`](#source-pubmed-observation-pmid-40903014-2026-02-19-30e5f2588ae8))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40903014 at 2026-07-30T16:25:12.584Z. PubMed recorded a metadata revision date of 2026-02-19 and an Entrez history date of 2025-09-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40903014-2026-02-19-30e5f2588ae8`](#source-pubmed-observation-pmid-40903014-2026-02-19-30e5f2588ae8))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40903014-2026-02-19-30e5f2588ae8`](#source-pubmed-observation-pmid-40903014-2026-02-19-30e5f2588ae8))

### Sources

<a id="source-pubmed-observation-pmid-40903014-2026-02-19-30e5f2588ae8"></a>
- **PubMed record PMID 40903014 · retained source version 1:2026-02-19:current:30e5f2588ae8a698646372416a715e07334728f43942af9f03d7412975cf4f83** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40903014/) (`pubmed-observation-pmid-40903014-2026-02-19-30e5f2588ae8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40903014." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-40903014-setmelanotide-v1 SHA-256: eb64ee6cc4d38dd5e8c0190165d027cb9bd3b76508403935885bbcf0883676e3.

---

<a id="pubmed-pmid-41401696-setmelanotide-v1"></a>

## PubMed record PMID 41401696

> PeptideScanner retained PubMed bibliographic metadata for PMID 41401696 at 2026-07-30T16:22:18.312Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2025-12-16. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41401696-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41401696-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41401696-setmelanotide-v1
- Content SHA-256: `39c1649b1347326a486a3395f8046ecd0a124e212569be3599975e18905ec541`

### Claims and source pins

#### Headline

PubMed record PMID 41401696 ([`pubmed-observation-pmid-41401696-2026-04-17-f2688e967d2b`](#source-pubmed-observation-pmid-41401696-2026-04-17-f2688e967d2b))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41401696 at 2026-07-30T16:22:18.312Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2025-12-16. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41401696-2026-04-17-f2688e967d2b`](#source-pubmed-observation-pmid-41401696-2026-04-17-f2688e967d2b))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41401696 at 2026-07-30T16:22:18.312Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2025-12-16. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41401696-2026-04-17-f2688e967d2b`](#source-pubmed-observation-pmid-41401696-2026-04-17-f2688e967d2b))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41401696-2026-04-17-f2688e967d2b`](#source-pubmed-observation-pmid-41401696-2026-04-17-f2688e967d2b))

### Sources

<a id="source-pubmed-observation-pmid-41401696-2026-04-17-f2688e967d2b"></a>
- **PubMed record PMID 41401696 · retained source version 1:2026-04-17:current:f2688e967d2bfe6e02e69cb4f73999ebee9e5b112ca3ca636007e26be258a5d5** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41401696/) (`pubmed-observation-pmid-41401696-2026-04-17-f2688e967d2b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41401696." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41401696-setmelanotide-v1 SHA-256: 39c1649b1347326a486a3395f8046ecd0a124e212569be3599975e18905ec541.

---

<a id="pubmed-pmid-41601974-setmelanotide-v1"></a>

## PubMed record PMID 41601974

> PeptideScanner retained PubMed bibliographic metadata for PMID 41601974 at 2026-07-30T16:31:25.541Z. PubMed recorded a metadata revision date of 2026-01-31 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41601974-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-31
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41601974-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41601974-setmelanotide-v1
- Content SHA-256: `4b09d01765e5028cabd1e096cf0bb55ad277e5cb77f53e14020b17edaa445016`

### Claims and source pins

#### Headline

PubMed record PMID 41601974 ([`pubmed-observation-pmid-41601974-2026-01-31-a3d6a24cf68d`](#source-pubmed-observation-pmid-41601974-2026-01-31-a3d6a24cf68d))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41601974 at 2026-07-30T16:31:25.541Z. PubMed recorded a metadata revision date of 2026-01-31 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41601974-2026-01-31-a3d6a24cf68d`](#source-pubmed-observation-pmid-41601974-2026-01-31-a3d6a24cf68d))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41601974 at 2026-07-30T16:31:25.541Z. PubMed recorded a metadata revision date of 2026-01-31 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41601974-2026-01-31-a3d6a24cf68d`](#source-pubmed-observation-pmid-41601974-2026-01-31-a3d6a24cf68d))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41601974-2026-01-31-a3d6a24cf68d`](#source-pubmed-observation-pmid-41601974-2026-01-31-a3d6a24cf68d))

### Sources

<a id="source-pubmed-observation-pmid-41601974-2026-01-31-a3d6a24cf68d"></a>
- **PubMed record PMID 41601974 · retained source version 1:2026-01-31:current:a3d6a24cf68d45c8f194a130736c938716b4f522ebc0640cdb8e059188a14de8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41601974/) (`pubmed-observation-pmid-41601974-2026-01-31-a3d6a24cf68d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41601974." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41601974-setmelanotide-v1 SHA-256: 4b09d01765e5028cabd1e096cf0bb55ad277e5cb77f53e14020b17edaa445016.

---

<a id="pubmed-pmid-41866701-setmelanotide-v1"></a>

## PubMed record PMID 41866701

> PeptideScanner retained PubMed bibliographic metadata for PMID 41866701 at 2026-07-30T16:14:14.923Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2026-03-23. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41866701-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41866701-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41866701-setmelanotide-v1
- Content SHA-256: `6a467c7a6f6369874fb4873deba9688859dc46328c08ba240b5c7d343cd6cafd`

### Claims and source pins

#### Headline

PubMed record PMID 41866701 ([`pubmed-observation-pmid-41866701-2026-06-08-7d71247e9fd0`](#source-pubmed-observation-pmid-41866701-2026-06-08-7d71247e9fd0))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41866701 at 2026-07-30T16:14:14.923Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2026-03-23. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41866701-2026-06-08-7d71247e9fd0`](#source-pubmed-observation-pmid-41866701-2026-06-08-7d71247e9fd0))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41866701 at 2026-07-30T16:14:14.923Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2026-03-23. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41866701-2026-06-08-7d71247e9fd0`](#source-pubmed-observation-pmid-41866701-2026-06-08-7d71247e9fd0))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41866701-2026-06-08-7d71247e9fd0`](#source-pubmed-observation-pmid-41866701-2026-06-08-7d71247e9fd0))

### Sources

<a id="source-pubmed-observation-pmid-41866701-2026-06-08-7d71247e9fd0"></a>
- **PubMed record PMID 41866701 · retained source version 1:2026-06-08:current:7d71247e9fd06df5b7340010e804fa7bd6d8a7b343cf1a36445fb4437a599a3b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41866701/) (`pubmed-observation-pmid-41866701-2026-06-08-7d71247e9fd0`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41866701." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41866701-setmelanotide-v1 SHA-256: 6a467c7a6f6369874fb4873deba9688859dc46328c08ba240b5c7d343cd6cafd.

---

<a id="pubmed-pmid-41894554-setmelanotide-v1"></a>

## PubMed record PMID 41894554

> PeptideScanner retained PubMed bibliographic metadata for PMID 41894554 at 2026-08-10T18:13:44.905Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-03-27. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41894554-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-26
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41894554-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41894554-setmelanotide-v1
- Content SHA-256: `d4f52aa4df3287a84c845c4e578f55744925e89e640bd0eac284835dbcdb1827`

### Claims and source pins

#### Headline

PubMed record PMID 41894554 ([`pubmed-observation-pmid-41894554-2026-07-26-808f22187b85`](#source-pubmed-observation-pmid-41894554-2026-07-26-808f22187b85))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41894554 at 2026-08-10T18:13:44.905Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-03-27. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41894554-2026-07-26-808f22187b85`](#source-pubmed-observation-pmid-41894554-2026-07-26-808f22187b85))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41894554 at 2026-08-10T18:13:44.905Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-03-27. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41894554-2026-07-26-808f22187b85`](#source-pubmed-observation-pmid-41894554-2026-07-26-808f22187b85))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41894554-2026-07-26-808f22187b85`](#source-pubmed-observation-pmid-41894554-2026-07-26-808f22187b85))

### Sources

<a id="source-pubmed-observation-pmid-41894554-2026-07-26-808f22187b85"></a>
- **PubMed record PMID 41894554 · retained source version 1:2026-07-26:current:808f22187b85c04479b7d47b05557ffc37dbff434dbe121585d7117301474fbb** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41894554/) (`pubmed-observation-pmid-41894554-2026-07-26-808f22187b85`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41894554." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41894554-setmelanotide-v1 SHA-256: d4f52aa4df3287a84c845c4e578f55744925e89e640bd0eac284835dbcdb1827.

---

<a id="pubmed-pmid-41959165-setmelanotide-v1"></a>

## PubMed record PMID 41959165

> PeptideScanner retained PubMed bibliographic metadata for PMID 41959165 at 2026-07-30T16:22:18.487Z. PubMed recorded a metadata revision date of 2026-04-27 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41959165-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41959165-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41959165-setmelanotide-v1
- Content SHA-256: `236c58b748182ee68ec72f9206b526c7653dafbb668e4e9529dd262cb57bf356`

### Claims and source pins

#### Headline

PubMed record PMID 41959165 ([`pubmed-observation-pmid-41959165-2026-04-27-8e0e8263782b`](#source-pubmed-observation-pmid-41959165-2026-04-27-8e0e8263782b))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41959165 at 2026-07-30T16:22:18.487Z. PubMed recorded a metadata revision date of 2026-04-27 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41959165-2026-04-27-8e0e8263782b`](#source-pubmed-observation-pmid-41959165-2026-04-27-8e0e8263782b))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41959165 at 2026-07-30T16:22:18.487Z. PubMed recorded a metadata revision date of 2026-04-27 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41959165-2026-04-27-8e0e8263782b`](#source-pubmed-observation-pmid-41959165-2026-04-27-8e0e8263782b))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41959165-2026-04-27-8e0e8263782b`](#source-pubmed-observation-pmid-41959165-2026-04-27-8e0e8263782b))

### Sources

<a id="source-pubmed-observation-pmid-41959165-2026-04-27-8e0e8263782b"></a>
- **PubMed record PMID 41959165 · retained source version 1:2026-04-27:current:8e0e8263782b90ccb582496e94e5221c12fa5511647f2b65ae4f2dd669c453a1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41959165/) (`pubmed-observation-pmid-41959165-2026-04-27-8e0e8263782b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41959165." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41959165-setmelanotide-v1 SHA-256: 236c58b748182ee68ec72f9206b526c7653dafbb668e4e9529dd262cb57bf356.

---

<a id="pubmed-pmid-41994885-setmelanotide-v1"></a>

## PubMed record PMID 41994885

> PeptideScanner retained PubMed bibliographic metadata for PMID 41994885 at 2026-07-30T16:22:19.404Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2026-04-17. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41994885-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41994885-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41994885-setmelanotide-v1
- Content SHA-256: `3e87b4801556439ee9dbba9883cd2db645a328ee35c18008aa5134c057596eef`

### Claims and source pins

#### Headline

PubMed record PMID 41994885 ([`pubmed-observation-pmid-41994885-2026-04-17-68a80c43bbe9`](#source-pubmed-observation-pmid-41994885-2026-04-17-68a80c43bbe9))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41994885 at 2026-07-30T16:22:19.404Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2026-04-17. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41994885-2026-04-17-68a80c43bbe9`](#source-pubmed-observation-pmid-41994885-2026-04-17-68a80c43bbe9))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41994885 at 2026-07-30T16:22:19.404Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2026-04-17. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41994885-2026-04-17-68a80c43bbe9`](#source-pubmed-observation-pmid-41994885-2026-04-17-68a80c43bbe9))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41994885-2026-04-17-68a80c43bbe9`](#source-pubmed-observation-pmid-41994885-2026-04-17-68a80c43bbe9))

### Sources

<a id="source-pubmed-observation-pmid-41994885-2026-04-17-68a80c43bbe9"></a>
- **PubMed record PMID 41994885 · retained source version 1:2026-04-17:current:68a80c43bbe909816129f0e016ba9ca3b82d7d88b02eb518aa5f1d6a0ff11ce2** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41994885/) (`pubmed-observation-pmid-41994885-2026-04-17-68a80c43bbe9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41994885." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-41994885-setmelanotide-v1 SHA-256: 3e87b4801556439ee9dbba9883cd2db645a328ee35c18008aa5134c057596eef.

---

<a id="pubmed-pmid-42008191-setmelanotide-v1"></a>

## PubMed record PMID 42008191

> PeptideScanner retained PubMed bibliographic metadata for PMID 42008191 at 2026-08-10T10:49:08.851Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42008191-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-30
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42008191-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42008191-setmelanotide-v1
- Content SHA-256: `d2e26d2012591a9ac82eb195f2aa1e68676d18fcee6ddfda7e41ed444d482b05`

### Claims and source pins

#### Headline

PubMed record PMID 42008191 ([`pubmed-observation-pmid-42008191-2026-07-30-6c21bc75f740`](#source-pubmed-observation-pmid-42008191-2026-07-30-6c21bc75f740))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42008191 at 2026-08-10T10:49:08.851Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42008191-2026-07-30-6c21bc75f740`](#source-pubmed-observation-pmid-42008191-2026-07-30-6c21bc75f740))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42008191 at 2026-08-10T10:49:08.851Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42008191-2026-07-30-6c21bc75f740`](#source-pubmed-observation-pmid-42008191-2026-07-30-6c21bc75f740))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42008191-2026-07-30-6c21bc75f740`](#source-pubmed-observation-pmid-42008191-2026-07-30-6c21bc75f740))

### Sources

<a id="source-pubmed-observation-pmid-42008191-2026-07-30-6c21bc75f740"></a>
- **PubMed record PMID 42008191 · retained source version 1:2026-07-30:current:6c21bc75f7401cfdb6a88862622968e8947ed54a19cf25de759e8ecb66f6679b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42008191/) (`pubmed-observation-pmid-42008191-2026-07-30-6c21bc75f740`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42008191." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42008191-setmelanotide-v1 SHA-256: d2e26d2012591a9ac82eb195f2aa1e68676d18fcee6ddfda7e41ed444d482b05.

---

<a id="pubmed-pmid-42068058-setmelanotide-v1"></a>

## PubMed record PMID 42068058

> PeptideScanner retained PubMed bibliographic metadata for PMID 42068058 at 2026-07-30T16:20:43.725Z. PubMed recorded a metadata revision date of 2026-05-02 and an Entrez history date of 2026-05-02. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42068058-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-02
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42068058-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42068058-setmelanotide-v1
- Content SHA-256: `26363926b9aa3406428d9416a74922b7d23aa9e7661b4f123086ef7629712917`

### Claims and source pins

#### Headline

PubMed record PMID 42068058 ([`pubmed-observation-pmid-42068058-2026-05-02-54244e5a3da1`](#source-pubmed-observation-pmid-42068058-2026-05-02-54244e5a3da1))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42068058 at 2026-07-30T16:20:43.725Z. PubMed recorded a metadata revision date of 2026-05-02 and an Entrez history date of 2026-05-02. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42068058-2026-05-02-54244e5a3da1`](#source-pubmed-observation-pmid-42068058-2026-05-02-54244e5a3da1))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42068058 at 2026-07-30T16:20:43.725Z. PubMed recorded a metadata revision date of 2026-05-02 and an Entrez history date of 2026-05-02. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42068058-2026-05-02-54244e5a3da1`](#source-pubmed-observation-pmid-42068058-2026-05-02-54244e5a3da1))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42068058-2026-05-02-54244e5a3da1`](#source-pubmed-observation-pmid-42068058-2026-05-02-54244e5a3da1))

### Sources

<a id="source-pubmed-observation-pmid-42068058-2026-05-02-54244e5a3da1"></a>
- **PubMed record PMID 42068058 · retained source version 1:2026-05-02:current:54244e5a3da1f968dc030e9ae02553c59810caed5d57a657f0a24e17df76900a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42068058/) (`pubmed-observation-pmid-42068058-2026-05-02-54244e5a3da1`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42068058." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42068058-setmelanotide-v1 SHA-256: 26363926b9aa3406428d9416a74922b7d23aa9e7661b4f123086ef7629712917.

---

<a id="pubmed-pmid-42070740-setmelanotide-v1"></a>

## PubMed record PMID 42070740

> PeptideScanner retained PubMed bibliographic metadata for PMID 42070740 at 2026-07-30T16:14:16.709Z. PubMed recorded a metadata revision date of 2026-06-13 and an Entrez history date of 2026-05-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42070740-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42070740-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42070740-setmelanotide-v1
- Content SHA-256: `75d0b0f5ec93cf5609f35b32a287583533da72f0f5052a0f0daa670f6f116124`

### Claims and source pins

#### Headline

PubMed record PMID 42070740 ([`pubmed-observation-pmid-42070740-2026-06-13-192497e2b43c`](#source-pubmed-observation-pmid-42070740-2026-06-13-192497e2b43c))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42070740 at 2026-07-30T16:14:16.709Z. PubMed recorded a metadata revision date of 2026-06-13 and an Entrez history date of 2026-05-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42070740-2026-06-13-192497e2b43c`](#source-pubmed-observation-pmid-42070740-2026-06-13-192497e2b43c))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42070740 at 2026-07-30T16:14:16.709Z. PubMed recorded a metadata revision date of 2026-06-13 and an Entrez history date of 2026-05-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42070740-2026-06-13-192497e2b43c`](#source-pubmed-observation-pmid-42070740-2026-06-13-192497e2b43c))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42070740-2026-06-13-192497e2b43c`](#source-pubmed-observation-pmid-42070740-2026-06-13-192497e2b43c))

### Sources

<a id="source-pubmed-observation-pmid-42070740-2026-06-13-192497e2b43c"></a>
- **PubMed record PMID 42070740 · retained source version 1:2026-06-13:current:192497e2b43c4787aaf7160d9458686ce81100e17294d84b8dd97a0452e8380c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42070740/) (`pubmed-observation-pmid-42070740-2026-06-13-192497e2b43c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42070740." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42070740-setmelanotide-v1 SHA-256: 75d0b0f5ec93cf5609f35b32a287583533da72f0f5052a0f0daa670f6f116124.

---

<a id="pubmed-pmid-42205046-setmelanotide-v1"></a>

## PubMed record PMID 42205046

> PeptideScanner retained PubMed bibliographic metadata for PMID 42205046 at 2026-08-10T18:13:50.682Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-05-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42205046-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-06
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42205046-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42205046-setmelanotide-v1
- Content SHA-256: `5a859638119488245876d3874f08020778db2a95692d6092027e6d0c08e70b8d`

### Claims and source pins

#### Headline

PubMed record PMID 42205046 ([`pubmed-observation-pmid-42205046-2026-07-06-01d082a1acea`](#source-pubmed-observation-pmid-42205046-2026-07-06-01d082a1acea))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42205046 at 2026-08-10T18:13:50.682Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-05-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42205046-2026-07-06-01d082a1acea`](#source-pubmed-observation-pmid-42205046-2026-07-06-01d082a1acea))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42205046 at 2026-08-10T18:13:50.682Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-05-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42205046-2026-07-06-01d082a1acea`](#source-pubmed-observation-pmid-42205046-2026-07-06-01d082a1acea))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42205046-2026-07-06-01d082a1acea`](#source-pubmed-observation-pmid-42205046-2026-07-06-01d082a1acea))

### Sources

<a id="source-pubmed-observation-pmid-42205046-2026-07-06-01d082a1acea"></a>
- **PubMed record PMID 42205046 · retained source version 1:2026-07-06:current:01d082a1acea005594e7bb5d931a2c20920b311dc02d5be0ea4ba133b435dba8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42205046/) (`pubmed-observation-pmid-42205046-2026-07-06-01d082a1acea`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42205046." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42205046-setmelanotide-v1 SHA-256: 5a859638119488245876d3874f08020778db2a95692d6092027e6d0c08e70b8d.

---

<a id="pubmed-pmid-42329358-setmelanotide-v1"></a>

## PubMed record PMID 42329358

> PeptideScanner retained PubMed bibliographic metadata for PMID 42329358 at 2026-07-30T16:14:19.342Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2026-06-22. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42329358-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42329358-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42329358-setmelanotide-v1
- Content SHA-256: `b93d4250631d9ed9b6e36281aede0923130b3ac3279d1d33c580104b808b2bc3`

### Claims and source pins

#### Headline

PubMed record PMID 42329358 ([`pubmed-observation-pmid-42329358-2026-06-22-9decea3b54b0`](#source-pubmed-observation-pmid-42329358-2026-06-22-9decea3b54b0))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42329358 at 2026-07-30T16:14:19.342Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2026-06-22. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42329358-2026-06-22-9decea3b54b0`](#source-pubmed-observation-pmid-42329358-2026-06-22-9decea3b54b0))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42329358 at 2026-07-30T16:14:19.342Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2026-06-22. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42329358-2026-06-22-9decea3b54b0`](#source-pubmed-observation-pmid-42329358-2026-06-22-9decea3b54b0))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42329358-2026-06-22-9decea3b54b0`](#source-pubmed-observation-pmid-42329358-2026-06-22-9decea3b54b0))

### Sources

<a id="source-pubmed-observation-pmid-42329358-2026-06-22-9decea3b54b0"></a>
- **PubMed record PMID 42329358 · retained source version 1:2026-06-22:current:9decea3b54b050a0fe33a2d9210c10f5f914c2cfdf1d3df01aa27687b06c5ada** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42329358/) (`pubmed-observation-pmid-42329358-2026-06-22-9decea3b54b0`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42329358." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42329358-setmelanotide-v1 SHA-256: b93d4250631d9ed9b6e36281aede0923130b3ac3279d1d33c580104b808b2bc3.

---

<a id="pubmed-pmid-42339090-setmelanotide-v1"></a>

## PubMed record PMID 42339090

> PeptideScanner retained PubMed bibliographic metadata for PMID 42339090 at 2026-08-10T18:13:52.307Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-06-24. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42339090-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-14
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42339090-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42339090-setmelanotide-v1
- Content SHA-256: `0a4aa805f167109d43d4e097ba07053dece12ef4bc829666ac580bad0a769b1b`

### Claims and source pins

#### Headline

PubMed record PMID 42339090 ([`pubmed-observation-pmid-42339090-2026-07-14-1a2fee66ada9`](#source-pubmed-observation-pmid-42339090-2026-07-14-1a2fee66ada9))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42339090 at 2026-08-10T18:13:52.307Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-06-24. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42339090-2026-07-14-1a2fee66ada9`](#source-pubmed-observation-pmid-42339090-2026-07-14-1a2fee66ada9))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42339090 at 2026-08-10T18:13:52.307Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-06-24. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42339090-2026-07-14-1a2fee66ada9`](#source-pubmed-observation-pmid-42339090-2026-07-14-1a2fee66ada9))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42339090-2026-07-14-1a2fee66ada9`](#source-pubmed-observation-pmid-42339090-2026-07-14-1a2fee66ada9))

### Sources

<a id="source-pubmed-observation-pmid-42339090-2026-07-14-1a2fee66ada9"></a>
- **PubMed record PMID 42339090 · retained source version 1:2026-07-14:current:1a2fee66ada9b501673bb3361d74ee8fdc3759ef7b7fde3eb725ea71b996887b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42339090/) (`pubmed-observation-pmid-42339090-2026-07-14-1a2fee66ada9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42339090." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42339090-setmelanotide-v1 SHA-256: 0a4aa805f167109d43d4e097ba07053dece12ef4bc829666ac580bad0a769b1b.

---

<a id="pubmed-pmid-42418774-setmelanotide-v1"></a>

## PubMed record PMID 42418774

> PeptideScanner retained PubMed bibliographic metadata for PMID 42418774 at 2026-08-10T18:13:53.869Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42418774-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-09
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42418774-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42418774-setmelanotide-v1
- Content SHA-256: `0b1288ed8a39c6e38ec328af974127e2a0238be09ea72b656680688bfeda9bbd`

### Claims and source pins

#### Headline

PubMed record PMID 42418774 ([`pubmed-observation-pmid-42418774-2026-07-09-00b42fc43fe2`](#source-pubmed-observation-pmid-42418774-2026-07-09-00b42fc43fe2))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42418774 at 2026-08-10T18:13:53.869Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42418774-2026-07-09-00b42fc43fe2`](#source-pubmed-observation-pmid-42418774-2026-07-09-00b42fc43fe2))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42418774 at 2026-08-10T18:13:53.869Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42418774-2026-07-09-00b42fc43fe2`](#source-pubmed-observation-pmid-42418774-2026-07-09-00b42fc43fe2))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42418774-2026-07-09-00b42fc43fe2`](#source-pubmed-observation-pmid-42418774-2026-07-09-00b42fc43fe2))

### Sources

<a id="source-pubmed-observation-pmid-42418774-2026-07-09-00b42fc43fe2"></a>
- **PubMed record PMID 42418774 · retained source version 1:2026-07-09:current:00b42fc43fe22dc88ca8bc783c9267af94c8ede24ccd212ea35489f852b0d9ed** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42418774/) (`pubmed-observation-pmid-42418774-2026-07-09-00b42fc43fe2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42418774." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42418774-setmelanotide-v1 SHA-256: 0b1288ed8a39c6e38ec328af974127e2a0238be09ea72b656680688bfeda9bbd.

---

<a id="pubmed-pmid-42498078-setmelanotide-v1"></a>

## PubMed record PMID 42498078

> PeptideScanner retained PubMed bibliographic metadata for PMID 42498078 at 2026-08-10T10:49:10.787Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42498078-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-01
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42498078-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42498078-setmelanotide-v1
- Content SHA-256: `1d2eb232ea3b690cc947e9b238a4365c4de629c4a72c35ed5c2e0553ce5e7bb9`

### Claims and source pins

#### Headline

PubMed record PMID 42498078 ([`pubmed-observation-pmid-42498078-2026-08-01-986cc008ef78`](#source-pubmed-observation-pmid-42498078-2026-08-01-986cc008ef78))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42498078 at 2026-08-10T10:49:10.787Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42498078-2026-08-01-986cc008ef78`](#source-pubmed-observation-pmid-42498078-2026-08-01-986cc008ef78))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42498078 at 2026-08-10T10:49:10.787Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42498078-2026-08-01-986cc008ef78`](#source-pubmed-observation-pmid-42498078-2026-08-01-986cc008ef78))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42498078-2026-08-01-986cc008ef78`](#source-pubmed-observation-pmid-42498078-2026-08-01-986cc008ef78))

### Sources

<a id="source-pubmed-observation-pmid-42498078-2026-08-01-986cc008ef78"></a>
- **PubMed record PMID 42498078 · retained source version 1:2026-08-01:current:986cc008ef78b9c36ae3496e153e4293f42d62eb7d0166d829f0053f89f3b102** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42498078/) (`pubmed-observation-pmid-42498078-2026-08-01-986cc008ef78`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42498078." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42498078-setmelanotide-v1 SHA-256: 1d2eb232ea3b690cc947e9b238a4365c4de629c4a72c35ed5c2e0553ce5e7bb9.

---

<a id="pubmed-pmid-42528856-setmelanotide-v1"></a>

## PubMed record PMID 42528856

> PeptideScanner retained PubMed bibliographic metadata for PMID 42528856 at 2026-08-10T10:49:12.911Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42528856-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-30
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42528856-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42528856-setmelanotide-v1
- Content SHA-256: `2b2aa8d5ecf2aecfbe56104197ae618a7cd03a9ce03d9acd38fd3f55ad2d705e`

### Claims and source pins

#### Headline

PubMed record PMID 42528856 ([`pubmed-observation-pmid-42528856-2026-07-30-3009c9f7bdb6`](#source-pubmed-observation-pmid-42528856-2026-07-30-3009c9f7bdb6))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42528856 at 2026-08-10T10:49:12.911Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42528856-2026-07-30-3009c9f7bdb6`](#source-pubmed-observation-pmid-42528856-2026-07-30-3009c9f7bdb6))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42528856 at 2026-08-10T10:49:12.911Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42528856-2026-07-30-3009c9f7bdb6`](#source-pubmed-observation-pmid-42528856-2026-07-30-3009c9f7bdb6))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42528856-2026-07-30-3009c9f7bdb6`](#source-pubmed-observation-pmid-42528856-2026-07-30-3009c9f7bdb6))

### Sources

<a id="source-pubmed-observation-pmid-42528856-2026-07-30-3009c9f7bdb6"></a>
- **PubMed record PMID 42528856 · retained source version 1:2026-07-30:current:3009c9f7bdb67a87ccd094a751314d4b151b9f63f3f5970bfb4672091e5ea249** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42528856/) (`pubmed-observation-pmid-42528856-2026-07-30-3009c9f7bdb6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42528856." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42528856-setmelanotide-v1 SHA-256: 2b2aa8d5ecf2aecfbe56104197ae618a7cd03a9ce03d9acd38fd3f55ad2d705e.

---

<a id="pubmed-pmid-42538728-setmelanotide-v1"></a>

## PubMed record PMID 42538728

> PeptideScanner retained PubMed bibliographic metadata for PMID 42538728 at 2026-08-10T10:49:12.953Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42538728-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-01
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42538728-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42538728-setmelanotide-v1
- Content SHA-256: `62304bb17c9c691950a1ea12be1a3e8912983470e40009aa186dfbd5e575d2c6`

### Claims and source pins

#### Headline

PubMed record PMID 42538728 ([`pubmed-observation-pmid-42538728-2026-08-01-554eb90eafef`](#source-pubmed-observation-pmid-42538728-2026-08-01-554eb90eafef))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42538728 at 2026-08-10T10:49:12.953Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42538728-2026-08-01-554eb90eafef`](#source-pubmed-observation-pmid-42538728-2026-08-01-554eb90eafef))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42538728 at 2026-08-10T10:49:12.953Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42538728-2026-08-01-554eb90eafef`](#source-pubmed-observation-pmid-42538728-2026-08-01-554eb90eafef))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42538728-2026-08-01-554eb90eafef`](#source-pubmed-observation-pmid-42538728-2026-08-01-554eb90eafef))

### Sources

<a id="source-pubmed-observation-pmid-42538728-2026-08-01-554eb90eafef"></a>
- **PubMed record PMID 42538728 · retained source version 1:2026-08-01:current:554eb90eafef28807f556333c6de2b1729f8969e443d7e816a8dc6ae3d6f35e4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42538728/) (`pubmed-observation-pmid-42538728-2026-08-01-554eb90eafef`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42538728." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42538728-setmelanotide-v1 SHA-256: 62304bb17c9c691950a1ea12be1a3e8912983470e40009aa186dfbd5e575d2c6.

---

<a id="pubmed-pmid-42874119-setmelanotide-v1"></a>

## Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.

> PubMed lists PMID 42874119 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42874119-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-14
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42874119-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42874119-setmelanotide-v1
- Content SHA-256: `e6ac8e45c8a65e91869c0c8b9b0ae234a41415b7c71246816dab63938244f6aa`

### Claims and source pins

#### Headline

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. ([`pubmed-observation-pmid-42874119-2026-10-14-ddad325ad797`](#source-pubmed-observation-pmid-42874119-2026-10-14-ddad325ad797))

#### Summary

PubMed lists PMID 42874119 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42874119-2026-10-14-ddad325ad797`](#source-pubmed-observation-pmid-42874119-2026-10-14-ddad325ad797))

#### Paragraph 1

PubMed lists PMID 42874119 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42874119-2026-10-14-ddad325ad797`](#source-pubmed-observation-pmid-42874119-2026-10-14-ddad325ad797))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42874119-2026-10-14-ddad325ad797`](#source-pubmed-observation-pmid-42874119-2026-10-14-ddad325ad797))

### Sources

<a id="source-pubmed-observation-pmid-42874119-2026-10-14-ddad325ad797"></a>
- **Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. · retained source version 1:2026-10-14:current:ddad325ad797786127561129ec54671c2a1a37e88732c287549290cde3a1f120** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42874119/) (`pubmed-observation-pmid-42874119-2026-10-14-ddad325ad797`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide for the Treatment of Acquired Hypothalamic Obesity." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42874119-setmelanotide-v1 SHA-256: e6ac8e45c8a65e91869c0c8b9b0ae234a41415b7c71246816dab63938244f6aa.

---

<a id="pubmed-pmid-42874120-setmelanotide-v1"></a>

## Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.

> PubMed lists PMID 42874120 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42874120-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-14
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42874120-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42874120-setmelanotide-v1
- Content SHA-256: `e1884014dd469c9ed73ccb02a153f2b9547a59fb17039bdf8c83aad8ccb9a337`

### Claims and source pins

#### Headline

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. ([`pubmed-observation-pmid-42874120-2026-10-14-2da91ab04040`](#source-pubmed-observation-pmid-42874120-2026-10-14-2da91ab04040))

#### Summary

PubMed lists PMID 42874120 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42874120-2026-10-14-2da91ab04040`](#source-pubmed-observation-pmid-42874120-2026-10-14-2da91ab04040))

#### Paragraph 1

PubMed lists PMID 42874120 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42874120-2026-10-14-2da91ab04040`](#source-pubmed-observation-pmid-42874120-2026-10-14-2da91ab04040))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42874120-2026-10-14-2da91ab04040`](#source-pubmed-observation-pmid-42874120-2026-10-14-2da91ab04040))

### Sources

<a id="source-pubmed-observation-pmid-42874120-2026-10-14-2da91ab04040"></a>
- **Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. · retained source version 1:2026-10-14:current:2da91ab04040d05c65c731d60b72a01c50ed4ebc2c705a270234f2d48e0d2f59** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42874120/) (`pubmed-observation-pmid-42874120-2026-10-14-2da91ab04040`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide for the Treatment of Acquired Hypothalamic Obesity." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42874120-setmelanotide-v1 SHA-256: e1884014dd469c9ed73ccb02a153f2b9547a59fb17039bdf8c83aad8ccb9a337.

---

<a id="pubmed-pmid-42874121-setmelanotide-v1"></a>

## Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. Reply.

> PubMed lists PMID 42874121 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42874121-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-14
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42874121-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42874121-setmelanotide-v1
- Content SHA-256: `7f58f16d57daab00769d31bf92c35d615ebf620e0dce643b741dabe3424bdd6d`

### Claims and source pins

#### Headline

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. Reply. ([`pubmed-observation-pmid-42874121-2026-10-14-07d74af14123`](#source-pubmed-observation-pmid-42874121-2026-10-14-07d74af14123))

#### Summary

PubMed lists PMID 42874121 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42874121-2026-10-14-07d74af14123`](#source-pubmed-observation-pmid-42874121-2026-10-14-07d74af14123))

#### Paragraph 1

PubMed lists PMID 42874121 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42874121-2026-10-14-07d74af14123`](#source-pubmed-observation-pmid-42874121-2026-10-14-07d74af14123))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42874121-2026-10-14-07d74af14123`](#source-pubmed-observation-pmid-42874121-2026-10-14-07d74af14123))

### Sources

<a id="source-pubmed-observation-pmid-42874121-2026-10-14-07d74af14123"></a>
- **Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. Reply. · retained source version 1:2026-10-14:current:07d74af141239acc6794a6cd6c3047019f826c36222e866305f91529fefbc7ab** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42874121/) (`pubmed-observation-pmid-42874121-2026-10-14-07d74af14123`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. Reply." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-42874121-setmelanotide-v1 SHA-256: 7f58f16d57daab00769d31bf92c35d615ebf620e0dce643b741dabe3424bdd6d.

---

<a id="pubmed-pmid-43001579-setmelanotide-v1"></a>

## Early nutrition impacts later setmelanotide treatment of obesity in mice.

> PubMed lists PMID 43001579 in JCI insight as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-43001579-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-11-09
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-43001579-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-43001579-setmelanotide-v1
- Content SHA-256: `0997e2d90774b1b8d5f2fe038f06f2c7be572af1ab47fe554a058c0c81ba5fa3`

### Claims and source pins

#### Headline

Early nutrition impacts later setmelanotide treatment of obesity in mice. ([`pubmed-observation-pmid-43001579-2026-11-09-f97fa276f19f`](#source-pubmed-observation-pmid-43001579-2026-11-09-f97fa276f19f))

#### Summary

PubMed lists PMID 43001579 in JCI insight as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-43001579-2026-11-09-f97fa276f19f`](#source-pubmed-observation-pmid-43001579-2026-11-09-f97fa276f19f))

#### Paragraph 1

PubMed lists PMID 43001579 in JCI insight as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-43001579-2026-11-09-f97fa276f19f`](#source-pubmed-observation-pmid-43001579-2026-11-09-f97fa276f19f))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-43001579-2026-11-09-f97fa276f19f`](#source-pubmed-observation-pmid-43001579-2026-11-09-f97fa276f19f))

### Sources

<a id="source-pubmed-observation-pmid-43001579-2026-11-09-f97fa276f19f"></a>
- **Early nutrition impacts later setmelanotide treatment of obesity in mice. · retained source version 1:2026-11-09:current:f97fa276f19fb7a103865436a006fec301027b69240d08159756806c6cc37c76** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/43001579/) (`pubmed-observation-pmid-43001579-2026-11-09-f97fa276f19f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Early nutrition impacts later setmelanotide treatment of obesity in mice." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/setmelanotide.json#pubmed-pmid-43001579-setmelanotide-v1 SHA-256: 0997e2d90774b1b8d5f2fe038f06f2c7be572af1ab47fe554a058c0c81ba5fa3.

